Datasets:
hackint0sh
/
Text-Clinical-Records

Dataset card Data Studio Files Community
text
stringlengths
0
197k
<|newrecord|> nctId: NCT06275217 id: HMRF17182481 briefTitle: Mindful Yoga for Postpartum Depression overallStatus: RECRUITING date: 2021-01-08 date: 2025-07-15 date: 2025-12-31 date: 2024-02-23 date: 2024-02-23 name: The Hong Kong Polytechnic University class: OTHER briefSummary: This is a parallel-group randomized controlled trial. A total of 198 postpartum women with depressive symptoms (EPDS scores≥8 at baseline) will be recruited and randomized into two groups: 10-week mindful yoga intervention and 10-week psychoeducation program. Clinical assessment of depression, self-report questionnaires and salivary cortisol tests will be performed at baseline, after 10-week intervention, and at 6-month and 12-month follow-ups. The investigators expected that the mindful yoga intervention will reduce depression after 10 weeks compared to psychoeducation. The mindful yoga intervention will further reduce anxiety, stress, improve quality of life and sleep, and steepen diurnal cortisol slopes. These effects will be maintained for at least six months. conditions: Mood Disorders studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: OUTCOMES_ASSESSOR count: 198 type: ESTIMATED name: Mindfulness-based yoga program name: Psychoeducation measure: Edinburgh Postnatal Depression Scale measure: Depression Anxiety Stress Scale-Depression measure: Depression Anxiety Stress Scale-Anxiety measure: Depression Anxiety Stress Scale-Stress measure: Pittsburgh Sleep Quality Index measure: 36 Item-Short Form Health Survey Questionnaire measure: Five Facet Mindfulness Questionnaire measure: Pregnancy Symptom Inventory measure: Cortisol concentration level measure: Physical fitness measure: Balance sex: FEMALE minimumAge: 18 Years maximumAge: 60 Years stdAges: ADULT facility: The Hong Kong Polytechnic University status: RECRUITING city: Hong Kong country: Hong Kong name: Jessie JX Lin, PhD role: CONTACT email: jx-jessie.lin@polyu.edu.hk lat: 22.27832 lon: 114.17469 hasResults: False
<|newrecord|> nctId: NCT06275204 id: 101101252 id: 101101252 type: OTHER_GRANT domain: EU4H-2022-PJ-01 briefTitle: H. Pylori Screen-and-treat Study in a Population of Young Adults overallStatus: RECRUITING date: 2024-03-04 date: 2026-10-01 date: 2026-12-01 date: 2024-02-23 date: 2024-03-05 name: University of Latvia class: OTHER name: Clinical Hospital Center Rijeka name: Clinical Hospital Centre Zagreb name: Beacon Hospital name: Wroclaw Medical University name: Iuliu Hatieganu University of Medicine and Pharmacy name: National Institute of Public Health, Slovenia briefSummary: Gastric cancer remains a major challenge to public health on a global scale. H. pylori related cancer burden contributes to the largest proportion of cancer cases attributable to infections in Europe. Considering its absolute burden and persisting disparities, in addition to the substantial prevalence of H. pylori infection worldwide that is treatable, gastric cancer is a logical target for urgent action for prevention. Population-based H. pylori test-and-treat has therefore been proposed as a strategy for gastric cancer prevention. To fill the gaps in knowledge about gastric cancer prevention through H. pylori screening and eradication in younger adults, a study of a population-based H. pylori test-and-treat strategy in Ireland, Croatia, Latvia, Poland, Romania and Slovenia.
Main goals of this study are to assess future program processes, feasibility, acceptability and effectiveness. In total of 6,800 adults aged 30-34 will be tested for H. pylori infection. They will be randomly selected to represent the chosen population and invited to participate in the study based on informed consent. Confirmed infections will be treated by available combined therapy in line with treatment guidelines and the success of eradication will be retested during a control check-up.
Patients who will provide their consent to participate will undertake an interview about the risk factors in early childhood and their habits regarding alcohol consumption and use of tobacco. Compliance to testing and treatment, treatment results, adverse effects and reasons for dropping out will be additionally monitored. Gathered data will be analysed in alignment with our research questions. The investigators will disseminate reports and present the results to both the general public and the scientific community in order to foster future developments in gastric cancer prevention. conditions: Gastric Cancer conditions: H Pylori Infection conditions: H Pylori Eradication conditions: H-pylori studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 6800 type: ESTIMATED name: Bismuth-based quadruple therapy name: Levofloxacin-based quadruple therapy name: Standard triple therapy name: Levofloxacin-based triple measure: Healthcare workers' assessment of feasibility and acceptability of the proposed practical implementation of a screening program measure: Eradication rate of infection with H. pylori measure: Description of the adverse events profile measure: Participation rate of subjects selected for the program sex: ALL minimumAge: 30 Years maximumAge: 34 Years stdAges: ADULT facility: University Hospital Centre Zagreb status: RECRUITING city: Zagreb state: Grad Zagreb zip: 10000 country: Croatia name: Masa Cavlina Sevo, MD role: CONTACT phone: 00385995900847 email: masa.cavlina@gmail.com name: Mirjana Kalauz, Asst. Prof. role: CONTACT phone: 0038598519088 email: mirjanakalauz1@gmail.com name: Mirjana Kalauz, Asst. Prof. role: PRINCIPAL_INVESTIGATOR name: Pave Markos, MD, PhD role: SUB_INVESTIGATOR name: Tihomir Bradic, MD role: SUB_INVESTIGATOR name: Masa Cavlina Sevo, MD role: SUB_INVESTIGATOR lat: 45.81444 lon: 15.97798 facility: Clinical Hospital Center Rijeka status: RECRUITING city: Rijeka zip: 51000 country: Croatia name: Sandra Milic, MD role: CONTACT phone: 0038551658122 email: smilic05@gmail.com lat: 45.32674 lon: 14.44239 facility: Beacon Hospital status: RECRUITING city: Dublin zip: D18 AK68 country: Ireland name: Charlene Deane, MB Bch BAO, MSc role: CONTACT phone: 00353879114305 email: charlene.deane@beaconhospital.ie name: Ruth Pilkington, MB BcH BAO role: CONTACT phone: 0035312937521 email: ruth.pilkington@beaconhospital.ie name: Colm O Morain, MD, MB BcH BAO, FRCPI role: PRINCIPAL_INVESTIGATOR name: Orlaith Kelly, PHD, MB BcH role: SUB_INVESTIGATOR name: Charlene Deane, MB Bch BAO, MSc, MRCP role: SUB_INVESTIGATOR lat: 53.33306 lon: -6.24889 facility: Clinical and Preventive Medicine of the University of Latvia status: NOT_YET_RECRUITING city: Riga zip: LV1079 country: Latvia name: Marcis Leja, MD, PhD role: CONTACT phone: 371+29497500 email: marcis.leja@lu.lv name: Marcis Leja, MD, PhD role: PRINCIPAL_INVESTIGATOR name: Danute Razuka Ebela, MD, PhD role: SUB_INVESTIGATOR name: Linda Mezmale, MD role: SUB_INVESTIGATOR lat: 56.946 lon: 24.10589 facility: Wroclaw Medical University status: RECRUITING city: Wroclaw zip: 50-367 country: Poland name: Katarzyna Malinowska role: CONTACT phone: 00487178417 99 email: k.malinowska@umw.edu.pl name: Elzbieta Olejnik role: CONTACT phone: 00717841666 email: elzbieta.olejnik@umw.edu.pl name: Katarzyna Neubauer, MD, PhD, Assoc. Prof. role: PRINCIPAL_INVESTIGATOR name: Radoslaw Kempinski, MD, PhD role: SUB_INVESTIGATOR lat: 51.1 lon: 17.03333 facility: Iuliu Hatieganu University of Medicine and Pharmacy status: RECRUITING city: Cluj-Napoca state: Cluj County zip: 400003 country: Romania name: Dan Lucian Dumitrascu, Prof role: CONTACT phone: 0040722756475 email: ddumitrascu@umfcluj.ro name: Radu Farcas, MD, PhD student role: CONTACT phone: 0040757554422 email: radufr@gmail.com name: Radu Farcas, MD, PhD student role: SUB_INVESTIGATOR lat: 46.76667 lon: 23.6 facility: National Institute of Public Health, Slovenia status: RECRUITING city: Ljubljana zip: 1000 country: Slovenia name: Mitja Oblak, MSc role: CONTACT phone: 0038612441541 email: Mitja.Oblak@nijz.si name: Tatjana Kofol, MD role: CONTACT phone: 0038612441484 email: Tatjana.Kofol@nijz.si name: Bojan Tepeš, prof., MD role: PRINCIPAL_INVESTIGATOR lat: 46.05108 lon: 14.50513 hasResults: False
<|newrecord|> nctId: NCT06275191 id: 80758 id: 1UG3DE032621-01 type: NIH link: https://reporter.nih.gov/quickSearch/1UG3DE032621-01 id: 4UH3DE032621-02 type: NIH link: https://reporter.nih.gov/quickSearch/4UH3DE032621-02 briefTitle: Alternatives to Dental Opioid Prescribing After Tooth Extraction acronym: ADOPT overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2028-01 date: 2028-12 date: 2024-02-23 date: 2024-03-06 name: Douglas Oyler class: OTHER name: National Institute of Dental and Craniofacial Research (NIDCR) briefSummary: The goal of this clinical trial is to test a three-item intervention in oral surgeons who remove teeth. The main questions it aims to answer are:
* Can the intervention reduce opioid prescriptions to adolescents and young adults after tooth removal?
* Do oral surgeons' beliefs about the intervention and opioid prescribing change?
* Do patients that report using opioids after tooth removal have different experiences than patients that do not?
Oral surgeon participants will:
* Attend a 1-hour education session with a trained pharmacist
* Receive patient instructions and blister packs of pain medicine to give to patients
* Complete 2 surveys about feasibility and appropriateness
Patient participants will complete a survey about pain and medication use after having a tooth removed.
Researchers will compare the intervention to usual care to see if it reduces opioid prescribing. conditions: Analgesics, Opioid conditions: Acute Pain conditions: Tooth Extraction conditions: Adolescent conditions: Acetaminophen conditions: Ibuprofen studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: SEQUENTIAL interventionModelDescription: Stepped wedge cluster randomized trial primaryPurpose: OTHER masking: DOUBLE maskingDescription: Blinding to the intervention is not possible in this study, as the intervention requires provider engagement. Provider participants and any clinic personnel will be blinded to the allocation sequence, and those not yet receiving the intervention will not be aware of the time at which they will have the intervention implemented. The study biostatistician will be aware of the allocation sequence.
At the beginning of each period, the study biostatistician will inform the research coordinator, project manager, academic detailing pharmacist, and PIs which cluster will be transitioning to the intervention condition next. This information will be used to facilitate scheduling academic detailing visits and coordinate blister pack and patient instructions material assembly. The clinic will be informed of their allocation during Visit 4 to facilitate scheduling academic detailing visits. whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 38159 type: ESTIMATED name: Multicomponent intervention name: Usual care measure: Odds of post-extraction opioid prescription to adolescent/young adults after tooth extraction measure: (Change in) intervention feasibility measure: (Change in) intervention appropriateness measure: (Change in) opioid prescribing feasibility measure: (Change in) opioid prescribing appropriateness measure: Self-reported pain measure: Self-reported pain interference measure: Self-reported pain satisfaction sex: ALL minimumAge: 12 Years maximumAge: 25 Years stdAges: CHILD stdAges: ADULT facility: University of Kentucky city: Lexington state: Kentucky zip: 40536 country: United States name: Jennifer Dolly Prothro, MPH role: CONTACT email: jenniferdolly@uky.edu name: Enif Dominguez, DDS role: SUB_INVESTIGATOR name: Patricia R Freeman, PhD role: SUB_INVESTIGATOR name: Hannah K Knudsen, PhD role: SUB_INVESTIGATOR name: Craig S Miller, DDS role: SUB_INVESTIGATOR name: Sharon L Walsh, PhD role: SUB_INVESTIGATOR name: Philip M Westgate, PhD role: SUB_INVESTIGATOR lat: 37.98869 lon: -84.47772 hasResults: False
<|newrecord|> nctId: NCT06275178 id: ZRJY2021-BJ08-02-04 briefTitle: Medical Thoracoscopy for Diagnosing Unexplained Pleural Effusion: a National Multicenter Retrospective Study overallStatus: NOT_YET_RECRUITING date: 2024-03-20 date: 2024-12-24 date: 2024-12-31 date: 2024-02-23 date: 2024-02-23 name: China-Japan Friendship Hospital class: OTHER briefSummary: This study is a national multicenter retrospective study. Patients with unexplained pleural effusion who underwent thoracoscopic or video-assisted thoracoscopic biopsy for patients in recent 10 years were retrospectively collected from multiple centers to understand the proportion and final etiological composition of pleural effusion in China. conditions: Pleural Effusion conditions: Pleural Effusion, Malignant conditions: Fibrinous Pleuritis studyType: OBSERVATIONAL observationalModel: CASE_ONLY timePerspective: RETROSPECTIVE count: 5000 type: ESTIMATED name: Medical thoracoscopy measure: The proportion of fibrinous pleurisy in Chinese population sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
<|newrecord|> nctId: NCT06275165 id: 202301754B0 briefTitle: The Effects of Acupressure on Improving Postoperative Gastrointestinal Symptom Distress in Esophageal Cancer Patients overallStatus: RECRUITING date: 2024-03-27 date: 2025-07-18 date: 2025-07-18 date: 2024-02-23 date: 2024-03-29 name: CHEN, CHIA-CHEN class: OTHER briefSummary: This study is a quasi-experimental design clinical trial with the primary objective of comparing the health status of patients with esophageal cancer. Participants were divided into an experimental group and a control group. Patients in the experimental group received routine care and acupressure for 5 consecutive days starting from the day after entering the ward after esophageal cancer surgery, in the control group, participants received routine care, and Participants were assessed on the Gastrointestinal Symptom Distress Scale at the end of the intervention. The aim of this study was to verify the effectiveness of acupressure in improving of gastrointestinal symptoms distress after esophageal cancer surgery. conditions: Esophageal Cancer conditions: Gastrointestinal Dysfunction studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Participants were divided into an experimental group and a control group. experimental group: received acupressure for 5 days in addition to regular care.
control group: received regular postoperative care. primaryPurpose: SUPPORTIVE_CARE masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 60 type: ESTIMATED name: acupressure measure: Change from Baseline in gastrointestinal symptom distress Scale at study day 5(end day) sex: ALL minimumAge: 18 Years maximumAge: 85 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Chang Gung Memotial Hospital status: RECRUITING city: Taoyuan country: Taiwan name: Chia-Chen Chen role: CONTACT phone: +886-3-3281200 phoneExt: 3005 email: mymychen73@gmail.com lat: 24.95233 lon: 121.20193 hasResults: False
<|newrecord|> nctId: NCT06275152 id: HDRIC-01 briefTitle: The Protective Effect of Remote Ischemic Conditioning on Residual Renal Function in Hemodialysis Patients (RIC-HD) acronym: RIC-HD overallStatus: ENROLLING_BY_INVITATION date: 2024-02-20 date: 2026-01-19 date: 2026-01-19 date: 2024-02-23 date: 2024-02-26 name: Yuanjun Yang class: OTHER briefSummary: Hemodialysis (HD) is the main renal replacement therapy for patients with end-stage renal disease. However, factors such as hemodynamic instability can lead to gradual loss of residual renal function (RRF) in HD patients. The loss of RRF not only affects the adequacy of dialysis and complications control but also impacts the patients' quality of life and survival. Unfortunately, there are currently no effective methods to protect RRF. The purpose of this study is to validate the protective effect of remote ischemic conditioning (RIC) on RRF in HD patients. This will provide evidence for the application of RIC in protecting RRF in HD patients. conditions: End-stage Renal Disease studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: randomized controlled pilot study primaryPurpose: PREVENTION masking: QUADRUPLE maskingDescription: Only Research Assistant will be unblinded. Participant, clinical team, PI, etc. will all be blinded to the randomization group. whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 60 type: ESTIMATED name: Remote ischemic conditioning name: Sham Remote Ischemic Conditioning measure: time to anuria measure: residual renal function (RRF) measure: Change in the renal cerebral oxygen saturation measure: serum creatinine measure: serum urea nitrogen measure: C-reactive protein (CRP) measure: Interleukin-6 measure: TFF3 measure: KIM-1 measure: IP-10 measure: hemoglobin measure: systolic pressure measure: diastolic pressure sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Chinese PLA General Hospital city: Beijing state: Beijing zip: 100853 country: China lat: 39.9075 lon: 116.39723 hasResults: False
<|newrecord|> nctId: NCT06275139 id: 2023-GSP-GG-9 briefTitle: Integrated Assessment of Cervicocerebral Vessels to Improve the Brain Injury for CAGB Patients (IACV Study) overallStatus: RECRUITING date: 2023-01-01 date: 2024-06-30 date: 2024-12-31 date: 2024-02-23 date: 2024-02-23 name: China National Center for Cardiovascular Diseases class: OTHER_GOV briefSummary: The goal of this study is to establish a prospective study to focus on the high-risk stroke population who require coronary artery bypass graft surgery. It will divide the eligible patients into 1:1 group by simple randomization method. The control group adopt the traditional diagnosis and treatment mode, and only head CT plain scan and carotid artery ultrasound shall be performed. If necessary, relevant disciplines would be consulted but no integrated assessment of cervicocerebral vessels be arranged. The final treatment plan would be decided by the surgeon alone. The experimental group adopt the multidisciplinary collaboration and integrated evaluation mode. In addition to routine diagnosis and treatment as above-mentioned, integrated assessment of cervicocerebral vessels shall be performed, including transcranial color-coded doppler, cerebral perfusion with multislice CT, and cognitive function assessment. Based on the above results, surgical plans will be formulated jointly by multiple disciplines including neurologists, vascular surgeons, ICU physicians and cardiac surgeons. Researchers will compare the two groups to investigate whether integrated assessment of cervicocerebral vessels can reduce the incidence of brain injury compared with conventional diagnosis and treatment mode. conditions: Coronary Disease conditions: Coronary Artery Bypass conditions: Strokes Thrombotic studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Integrated assessment of cervicocerebral vessels shall be performed, including transcranial color-coded doppler, cerebral perfusion with multislice CT, and cognitive function assessment. primaryPurpose: PREVENTION masking: NONE count: 348 type: ESTIMATED name: Integrated Assessment of Cervicocerebral Vessels measure: The incidence of neurological complications measure: The incidence of major adverse cardiac events measure: Neurological scale scores sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Fuwai Hospital; National Cardiovascular Center; Peking Union Medical College & Chinese Academy of Medical Sciences status: RECRUITING city: Beijing state: Beijing zip: 100037 country: China name: Huanmei Liu, MD role: CONTACT email: ncrc@fuwai.com lat: 39.9075 lon: 116.39723 hasResults: False
<|newrecord|> nctId: NCT06275126 id: 23-08026433 id: R01CA256877-01A1 type: NIH link: https://reporter.nih.gov/quickSearch/R01CA256877-01A1 briefTitle: Optimizing Surgical Decisions in Young Adults With Breast Cancer acronym: CONSYDER overallStatus: RECRUITING date: 2024-03-13 date: 2026-09 date: 2027-05 date: 2024-02-23 date: 2024-04-10 name: Weill Medical College of Cornell University class: OTHER name: National Institutes of Health (NIH) name: National Cancer Institute (NCI) briefSummary: The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evaluate the impact and use a web-based tool called CONSYDER that is designed to provide useful information to young breast cancer patients. It is also meant to improve communication between young women and their surgeons with the purpose of helping patients make appropriate surgical decisions.
Participants will complete surveys within 1 week of the surgical consult and 6 months after surgery. Patients who receive neoadjuvant chemotherapy will also be surveyed after the completion of neoadjuvant treatment but prior to surgery. Some patients will be invited for an interview after their surgery as part of the evaluation. A subset of patients/surgeons will also have their surgical consultation audio-recorded. conditions: Breast Cancer Stage 0 conditions: Breast Cancer Stage I conditions: Breast Cancer Stage II conditions: Breast Cancer Stage III studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER interventionModelDescription: The study is a pragmatic, Type II hybrid effectiveness-implementation, stepped-wedge design that will incorporate a mixed-methods approach to test the efficacy and evaluate the implementation of the CONSYDER intervention primaryPurpose: HEALTH_SERVICES_RESEARCH masking: NONE count: 800 type: ESTIMATED name: CONSYDER decision aid measure: Pre-surgical decisional conflict as measured by the Decisional Conflict Scale (DCS) measure: Use of CONSYDER pre-consult measure: Knowledge as measured by adapted Breast Cancer Surgery Decision Quality Instrument (BCS -DQI) measure: Treatment goals and preferences as measured by adapted Breast Cancer Surgery Decision Quality Instrument (BCS-DQI) measure: Anxiety, as measured with the 8-item Patient Reported Outcomes Measurement Information System (PROMIS) - Anxiety - Short Form measure: Self-efficacy in communication as measured by the Perceived Efficacy in Patient-Physician Interactions scale (PEPPI). measure: Decisional regret as measured by the Decision Regret Scale (DRS) measure: Receipt of contralateral prophylactic mastectomy measure: Fidelity of implementation of CONSYDER via patient portal email measure: Use of CONSYDER post-consult measure: Frequency of CONSYDER use pre-consult measure: Frequency of CONSYDER use post-consult sex: FEMALE minimumAge: 18 Years maximumAge: 44 Years stdAges: ADULT facility: Yale Cancer Center status: RECRUITING city: New Haven state: Connecticut zip: 06510 country: United States name: Rachel Greenup, MD, MPH role: CONTACT phone: 203-737-2966 email: rachel.greenup@yale.edu name: Rachel Greenup, MD, MPH role: PRINCIPAL_INVESTIGATOR lat: 41.30815 lon: -72.92816 facility: Dana-Farber Cancer Institute status: RECRUITING city: Boston state: Massachusetts zip: 02215 country: United States name: Ann Partridge, MD, MPH role: CONTACT phone: 617-632-3800 email: ann_partridge@dfci.harvard.edu name: Ann Partridge, MD, MPH role: PRINCIPAL_INVESTIGATOR lat: 42.35843 lon: -71.05977 facility: Weill Cornell Medicine status: RECRUITING city: New York state: New York zip: 10065 country: United States name: Shoshana Rosenberg, ScD, MPH role: CONTACT phone: 646-962-8041 email: shr4009@med.cornell.edu name: Darima Dorzhieva role: CONTACT phone: 646-962-8666 email: dad4011@med.cornell.edu name: Shoshana Rosenberg, ScD, MPH role: PRINCIPAL_INVESTIGATOR lat: 40.71427 lon: -74.00597 facility: Duke Cancer Institute status: RECRUITING city: Durham state: North Carolina zip: 27710 country: United States name: Jennifer Plichta, MD, MS role: CONTACT phone: 919-681-9156 email: jennifer.plichta@duke.edu name: Jennifer Plichta, MD, MS role: PRINCIPAL_INVESTIGATOR lat: 35.99403 lon: -78.89862 hasResults: False
<|newrecord|> nctId: NCT06275113 id: K25 briefTitle: BRING-UP Prevention overallStatus: RECRUITING date: 2023-09-15 date: 2026-06-30 date: 2026-06-30 date: 2024-02-23 date: 2024-02-23 name: Heart Care Foundation class: OTHER briefSummary: The aim of this observational study is to assess in patients with a documented athero-thrombotic event: coronary artery disease (CAD), cerebrovascular disease (CVD), peripheral artery disease (PAD):
* the level of adherence to guideline recommendations with the assumption to improve the rate of patients at goal for cholesterol levels.
* the level of adherence to guideline recommendations and the rate of patients at goal for the other relevant and modifiable risk factors for cardiovascular event recurrence. conditions: Ischemic Heart Disease conditions: Cerebrovascular Disorders conditions: Peripheral Arterial Disease studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 6000 type: ESTIMATED measure: Adherence to guideline for cholesterol level measure: Adherence to guideline for other risk factors measure: Patients' outcome sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Ospedale Barone Lombardo - Cardiologia E Utic status: NOT_YET_RECRUITING city: Canicatti' state: AG zip: 92024 country: Italy name: LUCIANO SUTERA SARDO, MD role: CONTACT lat: 37.35842 lon: 13.84786 facility: Ospedale San Giacomo D'Altopasso - Uoc Cardiologia status: RECRUITING city: Licata state: AG zip: 92027 country: Italy name: SALVATORE MONTALTO, MD role: CONTACT lat: 37.10267 lon: 13.93972 facility: Ospedale Santo Spirito - Sc Cardiologia status: RECRUITING city: Casale Monferrato state: AL zip: 15033 country: Italy name: FEDERICO NARDI, MD role: CONTACT lat: 45.13338 lon: 8.4525 facility: Ospedale San Giacomo - Sc Cardiologia status: RECRUITING city: Novi Ligure state: AL zip: 15067 country: Italy name: MARIA E ROVERE, MD role: CONTACT lat: 44.76246 lon: 8.787 facility: Ospedali Riuniti - Clinica Di Cardiologia E Aritmologia status: NOT_YET_RECRUITING city: Ancona state: AN zip: 60122 country: Italy name: PAOLO COMPAGNUCCI, MD role: CONTACT lat: 43.5942 lon: 13.50337 facility: Ospedali Riuniti - Sod Cardiologia Ospedaliera E Utic status: NOT_YET_RECRUITING city: Ancona state: AN zip: 60122 country: Italy name: GIAN PIERO PERNA, MD role: CONTACT lat: 43.5942 lon: 13.50337 facility: Casa Di Cura Villa Serena - U.O. Cardiologia Riabilitativa status: RECRUITING city: Jesi state: AN zip: 60035 country: Italy name: NICOLA RUSSO, MD role: CONTACT lat: 43.52142 lon: 13.24368 facility: Ospedale Madonna Del Soccorso - Uoc Cardiologia Indirizzo Riabilitativo status: RECRUITING city: San Benedetto Del Tronto state: AP zip: 63074 country: Italy name: MICHELA MOLISANA, MD role: CONTACT lat: 42.9568 lon: 13.87676 facility: Ospedale San Donato - U.O.C Cardiologia status: RECRUITING city: Arezzo state: AR zip: 52100 country: Italy name: MATTEO ROCCO RECCIA, MD role: CONTACT lat: 43.46276 lon: 11.88068 facility: Ospedale Valdichiana Santa Margherita - Uosd Cardiologia S.O. Cortona status: RECRUITING city: Cortona state: AR zip: 52044 country: Italy name: SIMONA D'ORAZIO, MD role: CONTACT lat: 43.27467 lon: 11.98533 facility: Aorn San Giuseppe Moscati - U.O. Cardiologia/Utic 'D. Rotiroti' status: RECRUITING city: Avellino state: AV zip: 83100 country: Italy name: EMILIO DI LORENZO, MD role: CONTACT lat: 40.91494 lon: 14.79103 facility: Ospedale Miulli - U.O.C. Cardiologia - Utic status: RECRUITING city: Acquaviva Delle Fonti state: BA zip: 70021 country: Italy name: NICOLA VITULANO, MD role: CONTACT lat: 40.89704 lon: 16.8433 facility: Ospedale Della Murgia - Fabio Perinei - S.C. Cardiologia-Utic status: RECRUITING city: Altamura state: BA zip: 70022 country: Italy name: PIETRO SCICCHITANO, MD role: CONTACT lat: 40.82664 lon: 16.54952 facility: Ospedale San Paolo - Cardiologia-Utic status: RECRUITING city: Bari state: BA zip: 70123 country: Italy name: PASQUALE CALDAROLA, MD role: CONTACT lat: 41.11148 lon: 16.8554 facility: Ics Maugeri Spa Societa' Benefit Irccs Bari - Cardiologia Riabilitativa status: RECRUITING city: Bari state: BA zip: 70124 country: Italy name: ANDREA PASSANTINO, MD role: CONTACT lat: 41.11148 lon: 16.8554 facility: Mater Dei Hospital - Riabilitazione Cardiologica status: RECRUITING city: Bari state: BA zip: 70124 country: Italy name: ROCCO LAGIOIA, MD role: CONTACT lat: 41.11148 lon: 16.8554 facility: Ospedale Umberto I - U.O.C. Cardiologia status: RECRUITING city: Corato state: BA zip: 70033 country: Italy name: ILARIA L NALIN, MD role: CONTACT lat: 41.15171 lon: 16.41143 facility: Ospedale San Giacomo - Uoc Cardiologia status: RECRUITING city: Monopoli state: BA zip: 70043 country: Italy name: ONOFRIO ROSSI, MD role: CONTACT lat: 40.94918 lon: 17.29717 facility: Ospedale Degli Infermi - Sc Di Cardiologia status: RECRUITING city: Ponderano state: BI zip: 13875 country: Italy name: ANDREA ROGNONI, MD role: CONTACT lat: 45.53846 lon: 8.05592 facility: Presidio Ospedaliero "Santa Maria Del Prato" - U.O.C. Di Cardiologia-Utic status: RECRUITING city: Feltre state: BL zip: 32032 country: Italy name: CHRISTIAN PIERGENTILI, MD role: CONTACT lat: 46.02085 lon: 11.90031 facility: Ospedale Di Bentivoglio - U.O. Cardiologia Pianura status: RECRUITING city: Bentivoglio state: BO zip: 40010 country: Italy name: GIANFRANCO TORTORICI, MD role: CONTACT lat: 44.6369 lon: 11.41737 facility: Ospedale Maggiore - U.O.C. Di Cardiologia status: RECRUITING city: Bologna state: BO zip: 40133 country: Italy name: GIANMARCO IANNOPOLLO, MD role: CONTACT lat: 44.49381 lon: 11.33875 facility: Ospedale Bellaria - U.O. Di Cardiologia status: RECRUITING city: Bologna state: BO zip: 40139 country: Italy name: STEFANO URBINATI, MD role: CONTACT lat: 44.49381 lon: 11.33875 facility: Ospedale Perrino - U.O.C. Di Cardiologia status: RECRUITING city: Brindisi state: BR zip: 72100 country: Italy name: GIAN PAOLO GIORDA, MD role: CONTACT lat: 40.63215 lon: 17.93607 facility: Casa Di Cura San Camillo - U.O. Cardiologia status: RECRUITING city: Brescia state: BS zip: 25123 country: Italy name: MARCO CAPRETTI, MD role: CONTACT lat: 45.53558 lon: 10.21472 facility: Ospedale Di Desenzano Del Garda - Divisione Di Cardiologia - U.C.C. status: RECRUITING city: Desenzano Del Garda state: BS zip: 25015 country: Italy name: GIOSUE' MASCIOLI, MD role: CONTACT lat: 45.47127 lon: 10.53559 facility: Ospedale Civile 'La Memoria' - U.O. Di Cardiologia status: RECRUITING city: Gavardo state: BS zip: 25085 country: Italy name: MARCO TRIGGIANI, MD role: CONTACT lat: 45.58939 lon: 10.44257 facility: Istituti Clinici Scientifici Maugeri Irccs Sede Di Lumezzane - U.O. Di Cardiologia Riabilitativa status: RECRUITING city: Lumezzane state: BS zip: 25065 country: Italy name: FRANCESCA RIVADOSSI, MD role: CONTACT lat: 45.64789 lon: 10.26487 facility: Ospedale Monsignor Angelo R. Di Miccoli - Uoc Cardiologia/Utic status: NOT_YET_RECRUITING city: Barletta state: BT zip: 76121 country: Italy name: FRANCESCO BARTOLOMUCCI, MD role: CONTACT lat: 41.31429 lon: 16.28165 facility: Ospedale Centrale Bolzano - Cardiologia E Prove Funzionali status: RECRUITING city: Bolzano state: BZ zip: 39100 country: Italy name: PRISCILLA MILEWSKI, MD role: CONTACT lat: 46.49067 lon: 11.33982 facility: Arnas G. Brotzu - Cardiologia Con Utic status: NOT_YET_RECRUITING city: Cagliari state: CA zip: 09134 country: Italy name: MARCO CORDA, MD role: CONTACT lat: 39.23054 lon: 9.11917 facility: Arnas G. Brotzu - S.S.D. Cardioriabilitazione status: RECRUITING city: Cagliari state: CA zip: 09134 country: Italy name: ANDREA BIANCO, MD role: CONTACT lat: 39.23054 lon: 9.11917 facility: A.O.U. Cagliari Policlinico Monserrato - Sc Cardiologia Utic Emodinamica status: NOT_YET_RECRUITING city: Monserrato state: CA zip: 09124 country: Italy name: ROBERTA MONTISCI, MD role: CONTACT lat: 39.25642 lon: 9.1444 facility: Azienda Ospedaliera S. Anna E S. Sebastiano - U.O. Cardiologia D'Emergenza Con Utic status: RECRUITING city: Caserta state: CE zip: 81100 country: Italy name: PAOLO CALABRO', MD role: CONTACT lat: 41.07262 lon: 14.33231 facility: Villa Delle Magnolie - Riabilitazione Cardiologica status: RECRUITING city: Castel Morrone state: CE zip: 81020 country: Italy name: FRANCESO PERONE, MD role: CONTACT lat: 41.12102 lon: 14.35473 facility: Casa Di Cura San Michele - Uo Cardiologia status: RECRUITING city: Maddaloni state: CE zip: 81024 country: Italy name: MARCO PEPE, MD role: CONTACT lat: 41.03578 lon: 14.3823 facility: Ospedale San Giuseppe E Melorio - U.O.C. Cardiologia Utic status: RECRUITING city: Santa Maria Capua Vetere state: CE zip: 81055 country: Italy name: PIETRO IODICE, MD role: CONTACT lat: 41.08156 lon: 14.25342 facility: Ospedale Policlinico Ss. Annunziata - Uoc Cardiologia-Utic status: NOT_YET_RECRUITING city: Chieti state: CH zip: 66013 country: Italy name: MARCO ZIMARINO, MD role: CONTACT lat: 42.34827 lon: 14.16494 facility: Santa Barbara Hospital - Cardiologia status: RECRUITING city: Gela state: CL zip: 93012 country: Italy name: GIUSEPPE LA ROSA, MD role: CONTACT lat: 37.07381 lon: 14.24038 facility: Azienda Ospedaliera Santa Croce E Carle - Sc Cardiologia status: RECRUITING city: Cuneo state: CN zip: 12100 country: Italy name: FRANCESCA GIORDANA, MD role: CONTACT lat: 44.39071 lon: 7.54828 facility: Ospedale Regina Montis Regalis - U.O. Cardiologia-Utic status: RECRUITING city: Mondovì state: CN zip: 12084 country: Italy name: MAURO FEOLA, MD role: CONTACT lat: 44.39603 lon: 7.81764 facility: Ospedale Maggiore Ss. Annunziata - Sc Cardiologia status: RECRUITING city: Savigliano state: CN zip: 12038 country: Italy name: MICHELE DE BENEDICTIS, MD role: CONTACT lat: 44.64808 lon: 7.65677 facility: Ospedale Oglio Po - U.O. Di Cardiologia-Utic status: RECRUITING city: Casalmaggiore state: CR zip: 26041 country: Italy name: CARLO PISCICELLI, MD role: CONTACT lat: 44.98981 lon: 10.42055 facility: Ospedale Annunziata - Uoc Cardiologia Interventistica status: RECRUITING city: Cosenza state: CS zip: 87100 country: Italy name: FRANCESCO GRECO, MD role: CONTACT lat: 39.2989 lon: 16.25307 facility: Ospedale Spoke Paola- Cetraro Po Paola - Utic Cardiologia status: RECRUITING city: Paola state: CS zip: 87027 country: Italy name: MARIA T MANES, MD role: CONTACT lat: 39.36313 lon: 16.03691 facility: Policlinico Di Catania Presidio San Marco - Cardiologia Utic status: NOT_YET_RECRUITING city: Catania state: CT zip: 95100 country: Italy name: ALESSIO G LA MANNA, MD role: CONTACT lat: 37.49223 lon: 15.07041 facility: P.O. Garibaldi-Nesima - Arnas Garibaldi - U.O.C. Di Cardiologia Con Utic status: RECRUITING city: Catania state: CT zip: 95122 country: Italy name: MICHELE M GULIZIA, MD role: CONTACT lat: 37.49223 lon: 15.07041 facility: P.O. "Materdomini" - A.O.U. "Renato Dulbecco" - Ssd Cardiologia Riabilitativa status: RECRUITING city: Catanzaro state: CZ zip: 88100 country: Italy name: DOMENICO ZUCCO, MD role: CONTACT lat: 38.88247 lon: 16.60086 facility: Ospedale G.B. Morgagni - L. Pierantoni - U.O. Cardiologia status: RECRUITING city: Forli' state: FC zip: 47121 country: Italy name: DANIELA SPARTA', MD role: CONTACT lat: 44.22177 lon: 12.04144 facility: Arcispedale Sant'Anna - U.O. Cardiologia status: RECRUITING city: Ferrara state: FE zip: 44124 country: Italy name: GABRIELE GUARDIGLI, MD role: CONTACT lat: 44.83804 lon: 11.62057 facility: Policlinico Riuniti - S.C. Di Cardiologia Universitaria-Utic status: RECRUITING city: Foggia state: FG zip: 71100 country: Italy name: NATALE D BRUNETTI, MD role: CONTACT lat: 41.45845 lon: 15.55188 facility: San Francesco Hospital - U.O.C. Cardiologia status: RECRUITING city: Foggia state: FG zip: 71122 country: Italy name: ALDO RUSSO, MD role: CONTACT lat: 41.45845 lon: 15.55188 facility: Ospedale Casa Sollievo Della Sofferenza - Cardiologia - Utic - Riabil Cardiologica status: RECRUITING city: San Giovanni Rotondo state: FG zip: 71013 country: Italy name: GIUSEPPE DI STOLFO, MD role: CONTACT lat: 41.70643 lon: 15.7277 facility: Aou Careggi - Riabilitazione Cardiologica status: RECRUITING city: Firenze state: FI zip: 50134 country: Italy name: COSTANZA BURGISSER, MD role: CONTACT lat: 43.77925 lon: 11.24626 facility: E.O. Ospedali Galliera - S. C. Cardiologia E U.T.I.C. status: RECRUITING city: Genova state: GE zip: 16128 country: Italy name: MARIA MOLFESE, MD role: CONTACT lat: 44.40478 lon: 8.94438 facility: Ospedale San Giovanni Di Dio - Sc Cardiologia (Gorizia-Monfalcone) status: RECRUITING city: Gorizia state: GO zip: 34170 country: Italy name: GERARDINA LARDIERI, MD role: CONTACT lat: 45.94088 lon: 13.62167 facility: Ospedale Civile San Polo - Sc Cardiologia (Gorizia-Monfalcone) status: NOT_YET_RECRUITING city: Monfalcone state: GO zip: 34074 country: Italy name: GERARDINA LARDIERI, MD role: CONTACT lat: 45.80463 lon: 13.53292 facility: Presidio Ospedaliero - U.O. Cardiologia status: RECRUITING city: Sanremo state: IM zip: 18038 country: Italy name: FABIO FERRARI, MD role: CONTACT lat: 43.81725 lon: 7.7772 facility: Ospedale Alessandro Manzoni - S.C. Di Cardiologia status: RECRUITING city: Lecco state: LC zip: 23900 country: Italy name: ROBERTO SPOLADORE, MD role: CONTACT lat: 45.85589 lon: 9.39704 facility: Presidio Ospedaliero F. Ferrari - Ssd Cardiologia - Utic status: RECRUITING city: Casarano state: LE zip: 73042 country: Italy name: DONATO MELISSANO, MD role: CONTACT lat: 40.01131 lon: 18.16237 facility: Ospedale San Giuseppe Da Copertino - U.O. Di Cardiologia status: NOT_YET_RECRUITING city: Copertino state: LE zip: 73043 country: Italy name: ALESSANDRO CALCAGNILE, MD role: CONTACT lat: 40.26821 lon: 18.0543 facility: Ospedale Vito Fazzi - Uoc Cardiologia-Utic Ed Emodinamica status: RECRUITING city: Lecce state: LE zip: 73100 country: Italy name: STEFANIA MARAZIA, MD role: CONTACT lat: 40.35481 lon: 18.17244 facility: Ospedale Ignazio Veris Delli Ponti - Uoc Cardiologia-Utic "E. Vilei" status: RECRUITING city: Scorrano state: LE zip: 73020 country: Italy name: COSIMO A GRECO, MD role: CONTACT lat: 40.09018 lon: 18.29993 facility: Ospedali Riuniti - U.O.C. Cardiologia E Utic status: RECRUITING city: Livorno state: LI zip: 57124 country: Italy name: FRANCESCO BELLINI, MD role: CONTACT lat: 43.54427 lon: 10.32615 facility: Istituto 'Marco Pasquali' Icot - Riabilitazione Cardiologica status: RECRUITING city: Latina state: LT zip: 04100 country: Italy name: ANTONIO GROSSI, MD role: CONTACT lat: 41.46614 lon: 12.9043 facility: Nuovo Ospedale Versilia - Sc Cardiologia status: RECRUITING city: Camaiore state: LU zip: 55041 country: Italy name: GIANCARLO CASOLO, MD role: CONTACT lat: 43.94265 lon: 10.29754 facility: Ospedale Giovanni Paolo Ii - Uosd Utic status: NOT_YET_RECRUITING city: Policoro state: Matera zip: 75025 country: Italy name: ANDREA ANDRIANI, MD role: CONTACT lat: 40.2128 lon: 16.67795 facility: Ospedale Pio Xi - U.O.C. Di Cardiologia status: RECRUITING city: Desio state: MB zip: 20832 country: Italy name: FELICE ACHILLI, MD role: CONTACT lat: 45.61831 lon: 9.20249 facility: Fondazione Irccs San Gerardo Dei Tintori - Ospedale San Gerardo - U.O.C. Cardiologia status: RECRUITING city: Monza state: MB zip: 20900 country: Italy name: LAURA F VALAGUSSA, MD role: CONTACT lat: 45.58005 lon: 9.27246 facility: Ospedale Di Seregno - Riabilitazione Specialistica Cardiologica status: RECRUITING city: Seregno state: MB zip: 20831 country: Italy name: ELISABETTA SCANZIANI, MD role: CONTACT lat: 45.65002 lon: 9.20548 facility: Nuovo Ospedale Di Vimercate - S.C. Cardiologia E Utic status: RECRUITING city: Vimercate state: MB zip: 20871 country: Italy name: DANIELA GRASSELLI, MD role: CONTACT lat: 45.61545 lon: 9.36801 facility: Ospedale Generale Provinciale - U.O. Cardiologia status: RECRUITING city: Macerata state: MC zip: 62100 country: Italy name: MICAELA CAPPONI, MD role: CONTACT lat: 43.29789 lon: 13.45293 facility: Iomi Istituto Ortopedico F. Scalabrino - Uo Cardiologia status: RECRUITING city: Messina state: ME zip: 98015 country: Italy name: ROBERTO CARUSO, MD role: CONTACT lat: 38.19394 lon: 15.55256 facility: Irccs Centro Neurolesi Bonino Pulejo - P.O Piemonte - Cardiologia E Utic status: RECRUITING city: Messina state: ME zip: 98124 country: Italy name: ANTONIO DUCA, MD role: CONTACT lat: 38.19394 lon: 15.55256 facility: Azienda Ospedaliera Papardo - U.O. Cardiologia Con Utic - Emodinamica status: RECRUITING city: Messina state: ME zip: 98158 country: Italy name: VITO PIPITONE, MD role: CONTACT lat: 38.19394 lon: 15.55256 facility: Ospedale Di Cernusco Sul Naviglio - U. O. Di Cardiologia E Ucc status: NOT_YET_RECRUITING city: Cernusco Sul Naviglio state: MI zip: 20063 country: Italy name: SERGIO SALA, MD role: CONTACT lat: 45.52526 lon: 9.33297 facility: Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico - Uoc Malattie Cardiovascolari status: RECRUITING city: Milano state: MI zip: 20122 country: Italy name: STEFANO CARUGO, MD role: CONTACT lat: 45.46427 lon: 9.18951 facility: Centro Cardiologico Monzino Irccs - Terapia Intensiva Cardiologica (Utic) status: RECRUITING city: Milano state: MI zip: 20138 country: Italy name: FILIPPO TOMBARA, MD role: CONTACT lat: 45.46427 lon: 9.18951 facility: Istituti Clinici Scientifici Maugeri Irccs Sede Di Milano - Riabilitazione Cardiologica status: RECRUITING city: Milano state: MI zip: 20138 country: Italy name: MAURIZIO BUSSOTTI, MD role: CONTACT lat: 45.46427 lon: 9.18951 facility: Istituti Clinici Scientifici Maugeri Irccs Sede Di Milano - Uo Cure Subacute status: RECRUITING city: Milano state: MI zip: 20138 country: Italy name: MARCO FROLDI, MD role: CONTACT lat: 45.46427 lon: 9.18951 facility: Irccs Santa Maria Nascente Fond. Don Gnocchi - Cardiologia Riabilitativa status: RECRUITING city: Milano state: MI zip: 20148 country: Italy name: ANDREA A MORASCHI, MD role: CONTACT lat: 45.46427 lon: 9.18951 facility: ASST SANTI PAOLO E CARLO - PO San Carlo - CARDIOLOGIA-UCC status: RECRUITING city: Milano state: MI zip: 20153 country: Italy name: MARTA RESCALDANI, MD role: CONTACT lat: 45.46427 lon: 9.18951 facility: Irccs Ospedale Galeazzi - Sant'Ambrogio - Cardiologia Universitaria Ed Imaging Cardiaco status: RECRUITING city: Milano state: MI zip: 20157 country: Italy name: EDOARDO CONTE, MD role: CONTACT lat: 45.46427 lon: 9.18951 facility: Asst Ospedale Metropolitano Niguarda - Diagnosi E Cure Terr. Malattie Cardiache status: RECRUITING city: Milano state: MI zip: 20159 country: Italy name: GIULIANA G MOMBELLI, MD role: CONTACT lat: 45.46427 lon: 9.18951 facility: Asst Ospedale Metropolitano Niguarda - Cardiologia 1 - Emodinamica status: RECRUITING city: Milano state: MI zip: 20162 country: Italy name: LAURA GARATTI, MD role: CONTACT lat: 45.46427 lon: 9.18951 facility: Asst Ospedale Metropolitano Niguarda - Cardiologia 4 - Diagnostica E Riabilitativa status: RECRUITING city: Milano state: MI zip: 20162 country: Italy name: ALESSANDRO MALOBERTI, MD role: CONTACT lat: 45.46427 lon: 9.18951 facility: Presidio Ospedaliero Di Passirana - Cardiologia Riabilitativa status: RECRUITING city: RHO state: MI zip: 20017 country: Italy name: ANNA FRISINGHELLI, MD role: CONTACT lat: 45.53245 lon: 9.0402 facility: Irccs Policlinico San Donato - Cardiologia Riabilitativa status: RECRUITING city: San Donato Milanese state: MI zip: 20097 country: Italy name: MASSIMO PIEPOLI, MD role: CONTACT lat: 45.41047 lon: 9.26838 facility: Irccs Policlinico Multimedica - Uo Di Cardiologia status: RECRUITING city: Sesto San Giovanni state: MI zip: 20099 country: Italy name: LUCA P ALBERTI, MD role: CONTACT lat: 45.53329 lon: 9.22585 facility: Ospedale Citta' Di Sesto San Giovanni - Sc Cardiologia-Ucc Asst Nord Milano (Bassini-Ssg) status: RECRUITING city: Sesto San Giovanni state: MI zip: 20099 country: Italy name: CAMILLA FACCHINI, MD role: CONTACT lat: 45.53329 lon: 9.22585 facility: Ospedale Santa Maria Bianca - U.O. Di Cardiologia status: RECRUITING city: Mirandola state: MO zip: 41037 country: Italy name: GIULIA NANNI, MD role: CONTACT lat: 44.88515 lon: 11.06902 facility: Ospedale Civile Di Baggiovara - U.O. Di Cardiologia status: RECRUITING city: Modena state: MO zip: 41126 country: Italy name: STEFANIA SANSONI, MD role: CONTACT lat: 44.64783 lon: 10.92539 facility: Ospedale Di Sassuolo - Cardiologia status: RECRUITING city: Sassuolo state: MO zip: 41049 country: Italy name: WALTER SACCO, MD role: CONTACT lat: 44.5432 lon: 10.7848 facility: Ospedale San Giovanni Di Dio - Uo Cardiologia - Utic status: RECRUITING city: Frattamaggiore state: Napoli zip: 80027 country: Italy name: FRANCESCO PIEMONTE, MD role: CONTACT lat: 40.9414 lon: 14.27588 facility: Fondazione G. Giglio - U.O. Di Cardiologia status: RECRUITING city: Cefalu' state: PA zip: 90015 country: Italy name: DONATELLA ARMATA, MD role: CONTACT lat: 38.03856 lon: 14.02285 facility: Ospedale Buccheri La Ferla Fatebenefratelli - Ssd Riabilitazione Cardiovascolare status: RECRUITING city: Palermo state: PA zip: 90123 country: Italy name: FILIPPO M SARULLO, MD role: CONTACT lat: 38.13205 lon: 13.33561 facility: Aou Policlinico P. Giaccone - U.O.C. Cardiologia status: RECRUITING city: Palermo state: PA zip: 90127 country: Italy name: GIUSEPPINA NOVO, MD role: CONTACT lat: 38.13205 lon: 13.33561 facility: Arnas P.O. Civico E Benfratelli - Uoc Utic status: RECRUITING city: Palermo state: PA zip: 90127 country: Italy name: IGNAZIO M SMECCA, MD role: CONTACT lat: 38.13205 lon: 13.33561 facility: Maria Eleonora Hospital - Cardiologia status: RECRUITING city: Palermo state: PA zip: 90135 country: Italy name: VINCENZO PERNICE, MD role: CONTACT lat: 38.13205 lon: 13.33561 facility: Aor Villa Sofia-Cervello P.O. Cervello - U.O. Cardiologia - Cervello status: RECRUITING city: Palermo state: PA zip: 90146 country: Italy name: VINCENZO POLIZZI, MD role: CONTACT lat: 38.13205 lon: 13.33561 facility: Aor Villa Sofia-Cervello Po Villa Sofia - Uoc Cardiologia E Utic E Emodinamica -Villa Sofia status: RECRUITING city: Palermo state: PA zip: 90146 country: Italy name: CARLO CICERONE, MD role: CONTACT lat: 38.13205 lon: 13.33561 facility: Ospedale Unico Della Val Tidone - Cardiologia E Riabilitazione status: RECRUITING city: Castel San Giovanni state: PC zip: 29015 country: Italy name: MARIATERESA DI DIO, MD role: CONTACT lat: 45.06014 lon: 9.43784 facility: Ospedale Civile 'Guglielmo Da Saliceto' - Uoc Cardiologia E Utic status: RECRUITING city: Piacenza state: PC zip: 29100 country: Italy name: DANIELA ASCHIERI, MD role: CONTACT lat: 45.05242 lon: 9.69342 facility: Ospedale Di Cittadella - U.O. Cardiologia status: RECRUITING city: Cittadella state: PD zip: 35013 country: Italy name: GAETANO POVOLO, MD role: CONTACT lat: 45.64523 lon: 11.78453 facility: Ospedale Civile Dello Spirito Santo - Cardiologia Con Utic status: RECRUITING city: Pescara state: PE zip: 65124 country: Italy name: DOMENICO DI CLEMENTE, MD role: CONTACT lat: 42.4584 lon: 14.20283 facility: Presidio Ospedaliero Citta' Di Castello - U.O. Cardiologia/Utic status: RECRUITING city: Citta' Di Castello state: PG zip: 06012 country: Italy name: ANDREA CHIOCCHINI, MD role: CONTACT lat: 43.46556 lon: 12.2375 facility: Ospedale Gubbio-Gualdo Tadino - U.O. Di Utic E Cardiologia status: RECRUITING city: Gubbio state: PG zip: 06024 country: Italy name: DEBORAH COSMI, MD role: CONTACT lat: 43.34996 lon: 12.57309 facility: Azienda Ospedaliera Di Perugia - S.C. Cardiologia status: RECRUITING city: Perugia state: PG zip: 06129 country: Italy name: FRANCESCO NOTARISTEFANO, MD role: CONTACT lat: 43.1122 lon: 12.38878 facility: Ospedale Ss. Cosma E Damiano - Sos Cardiologia status: RECRUITING city: Pescia state: Pistoia zip: 51017 country: Italy name: GAIA C MAGNAGHI, MD role: CONTACT lat: 43.8871 lon: 10.68849 facility: Ospedale Ss. Cosma E Damiano - Sos Riabilitazione Cardiologica status: RECRUITING city: Pescia state: Pistoia zip: 51017 country: Italy name: DUCCIO ROSSINI, MD role: CONTACT lat: 43.8871 lon: 10.68849 facility: Ftgm - Stabilimento Di Pisa - Cardiologia E Medicina Cardiovascolare status: RECRUITING city: Pisa state: PI zip: 56124 country: Italy name: MICHELE EMDIN, MD role: CONTACT lat: 43.70853 lon: 10.4036 facility: Auxilium Vitae Volterra - Riabilitazione Cardiologica status: RECRUITING city: Volterra state: PI zip: 56048 country: Italy name: NICOLA SCELZA, MD role: CONTACT lat: 43.40251 lon: 10.86152 facility: Presidio Ospedaliero Per La Salute Di Sacile - Cardiologia Preventiva E Riabilitativa status: RECRUITING city: Sacile state: PN zip: 33077 country: Italy name: ELISA LEIBALLI, MD role: CONTACT lat: 45.95412 lon: 12.50274 facility: Ospedale Di S. Vito Al Tagliamento - Ssd Cardiologia San Vito - Spilimbergo status: RECRUITING city: San Vito Al Tagliamento state: PN zip: 33078 country: Italy name: DANIELA PAVAN, MD role: CONTACT lat: 45.9168 lon: 12.85945 facility: Ospedale Civile - U.O.C. Cardiologia - Utic status: RECRUITING city: Fidenza state: PR zip: 43036 country: Italy name: GIOVANNI TORTORELLA, MD role: CONTACT lat: 44.86694 lon: 10.06039 facility: Istituto Don Gnocchi - U.O. Prevenzione E Riabilitazione Cardiovascolare status: RECRUITING city: Parma state: PR zip: 43100 country: Italy name: UMBERTO CAMAIORA, MD role: CONTACT lat: 44.79935 lon: 10.32618 facility: Presidio Ospedaliero San Salvatore - Cardiologia E Utic status: RECRUITING city: Pesaro state: PU zip: 61121 country: Italy name: SIMONE MAFFEI, MD role: CONTACT lat: 43.90921 lon: 12.9164 facility: Istituti Clinici Scientifici Maugeri Irccs Sede Di Pavia - U.O. Di Riabilitazione Cardiologica status: RECRUITING city: Pavia state: PV zip: 27100 country: Italy name: GIOVANNI FORNI, MD role: CONTACT lat: 45.19205 lon: 9.15917 facility: Ospedale Civile - U.O. Di Cardiologia status: RECRUITING city: Voghera state: PV zip: 27058 country: Italy name: TIZIANA SPEZZANO, MD role: CONTACT lat: 44.99151 lon: 9.01175 facility: Ospedale Civile - Uo Servizio Cardiologia status: RECRUITING city: Lugo state: RA zip: 48022 country: Italy name: GIULIA RICCI LUCCHI, MD role: CONTACT lat: 44.42137 lon: 11.91094 facility: Ospedale Civile Santa Maria Delle Croci - Uoc Cardiologia status: RECRUITING city: Ravenna state: RA zip: 48121 country: Italy name: ANDREA RUBBOLI, MD role: CONTACT lat: 44.41344 lon: 12.20121 facility: Ospedale Civile Di Guastalla - Sos Cardiologia E Riabilitazione Card Area Nord status: RECRUITING city: Guastalla state: RE zip: 42016 country: Italy name: ALESSANDRO NAVAZIO, MD role: CONTACT lat: 44.91172 lon: 10.66186 facility: Ospedale E. Franchini - S.O.S. Cardiologia status: RECRUITING city: Montecchio Emilia state: RE zip: 42027 country: Italy name: ELISABETTA CATELLANI, MD role: CONTACT lat: 44.69937 lon: 10.45211 facility: Po Santa Maria Nuova - Ausl Re Irccs - Soc Cardiologia Ospedaliera status: RECRUITING city: Reggio Emilia state: RE zip: 42100 country: Italy name: ALESSANDRO NAVAZIO, MD role: CONTACT lat: 44.69825 lon: 10.63125 facility: Ospedale Riccardo Guzzardi - U.O.C. Di Cardiologia-Utic status: RECRUITING city: Vittoria state: RG zip: 97019 country: Italy name: GIUSEPPE DI STABILE, MD role: CONTACT lat: 36.95151 lon: 14.52788 facility: P.O. San Camillo de Lellis - U.O.C. Cardiologia status: RECRUITING city: Rieti state: RI zip: 02100 country: Italy name: AMIR KOL, MD role: CONTACT lat: 42.40476 lon: 12.85735 facility: Ospedali Riuniti Anzio-Nettuno - U.O.C. Di Cardiologia - Utic status: RECRUITING city: Anzio state: RM zip: 00042 country: Italy name: NATALE DI BELARDINO, MD role: CONTACT lat: 41.45263 lon: 12.62157 facility: Ospedale Dei Castelli - U.O.C. Di Cardiologia E Utic status: RECRUITING city: Ariccia state: RM zip: 00072 country: Italy name: FRANCESCO MONTI, MD role: CONTACT lat: 41.72063 lon: 12.6723 facility: Ospedale Civile San Paolo - U.O.C. Cardiologia - Utic status: RECRUITING city: Civitavecchia state: RM zip: 00053 country: Italy name: SIMONE CALCAGNO, MD role: CONTACT lat: 42.09325 lon: 11.79674 facility: Ospedale L. Parodi Delfino - U.O.C. Di Cardiologia - Utic status: NOT_YET_RECRUITING city: Colleferro state: RM zip: 00034 country: Italy name: ROBERTA IPPEDICO, MD role: CONTACT lat: 41.72722 lon: 13.00481 facility: Icr Villa Delle Querce - Riabilitazione Cardiorespiratoria status: NOT_YET_RECRUITING city: Nemi state: RM zip: 00040 country: Italy name: MICHELE AZZARITO, MD role: CONTACT lat: 41.72185 lon: 12.71809 facility: P.O. San Filippo Neri - Asl Roma 1 - Cardiologia Clinica E Riabilitativa status: RECRUITING city: Roma state: RM zip: 00135 country: Italy name: FURIO COLIVICCHI, MD role: CONTACT lat: 41.89193 lon: 12.51133 facility: Inmi Lazzaro Spallanzani Irccs - Servizio Di Cardiologia Del Dipartimento Clinico status: RECRUITING city: Roma state: RM zip: 00149 country: Italy name: MARIA C GATTO, MD role: CONTACT lat: 41.89193 lon: 12.51133 facility: Ospedale San Camillo - Uoc Cardiologia status: RECRUITING city: Roma state: RM zip: 00152 country: Italy name: LEONARDO DE LUCA, MD role: CONTACT lat: 41.89193 lon: 12.51133 facility: Ospedale Sandro Pertini - Uoc Cardiologia status: RECRUITING city: Roma state: RM zip: 00157 country: Italy name: ANTONINO GRANATELLI, MD role: CONTACT lat: 41.89193 lon: 12.51133 facility: Ospedale Sandro Pertini - Uosd Cardiologia D'Urgenza status: RECRUITING city: Roma state: RM zip: 00157 country: Italy name: STEFANIA CHERUBINI, MD role: CONTACT lat: 41.89193 lon: 12.51133 facility: Fondazione Policlinico Universitario A. Gemelli Irccs - Uosd Cardiologia D'Urgenza status: NOT_YET_RECRUITING city: Roma state: RM zip: 00168 country: Italy name: GIOVANNA LIUZZO, MD role: CONTACT lat: 41.89193 lon: 12.51133 facility: Policlinico Casilino - U.O.C. Cardiologia status: RECRUITING city: Roma state: RM zip: 00169 country: Italy name: LEONARDO CALO', MD role: CONTACT lat: 41.89193 lon: 12.51133 facility: Osp. Fatebenefratelli Isola Tiberina - Uoc Cardiologia Diagnostica Interventistica-Utic status: NOT_YET_RECRUITING city: Roma state: RM zip: 00188 country: Italy name: MATTEO RUZZOLINI, MD role: CONTACT lat: 41.89193 lon: 12.51133 facility: Ospedale Sant'Andrea Di Roma - U.O.C. Cardiologia status: RECRUITING city: Roma state: RM zip: 00189 country: Italy name: EMANUELE BARBATO, MD role: CONTACT lat: 41.89193 lon: 12.51133 facility: Ospedale Santo Spirito - Uoc Cardiologia status: RECRUITING city: Roma state: RM zip: 00193 country: Italy name: MARINA DELFINI, MD role: CONTACT lat: 41.89193 lon: 12.51133 facility: Ospedale San Giovanni Evangelista - U.O.C. Di Cardiologia - Utic status: RECRUITING city: Tivoli state: RM zip: 00019 country: Italy name: ALFREDO POSTERARO, MD role: CONTACT lat: 41.95952 lon: 12.8016 facility: Ospedale Infermi - U.O. Cardiologia status: NOT_YET_RECRUITING city: Rimini state: RN zip: 47900 country: Italy name: ANDREA GARDI, MD role: CONTACT lat: 44.05755 lon: 12.56528 facility: Ospedale Maria Ss. Addolorata - U.O. Di Cardiologia Utic status: RECRUITING city: Eboli state: SA zip: 84025 country: Italy name: EDUARDO CAPUANO, MD role: CONTACT lat: 40.61747 lon: 15.05693 facility: Presidio Ospedaliero Umberto I - Uoc Cardiologia - Utic status: RECRUITING city: Nocera Inferiore state: SA zip: 84014 country: Italy name: MARIO PACILEO, MD role: CONTACT lat: 40.7454 lon: 14.64542 facility: Presidio Ospedaliero Luigi Curto - Uo Cardiologia-Utic status: RECRUITING city: Polla state: SA zip: 84035 country: Italy name: SILVIO SAPONARA, MD role: CONTACT lat: 40.51433 lon: 15.49715 facility: Aou S. Giovanni Di Dio-Ruggi D'Aragona - Cardiologia Intensiva Ospedaliera status: RECRUITING city: Salerno state: SA zip: 84131 country: Italy name: MICHELE R DI MURO, MD role: CONTACT lat: 40.67545 lon: 14.79328 facility: Aou S. Giovanni Di Dio-Ruggi D'Aragona - Ssd Utic status: RECRUITING city: Salerno state: SA zip: 84131 country: Italy name: AMELIA RAVERA, MD role: CONTACT lat: 40.67545 lon: 14.79328 facility: Aou S. Giovanni Di Dio-Ruggi D'Aragona - Uoc Clinica Cardiologica status: RECRUITING city: Salerno state: SA zip: 84131 country: Italy name: MICHELE CICCARELLI, MD role: CONTACT lat: 40.67545 lon: 14.79328 facility: Ospedale Villa Malta - Cardiologia E Utic status: RECRUITING city: Sarno state: SA zip: 84087 country: Italy name: MARIA C RUSSO, MD role: CONTACT lat: 40.80748 lon: 14.62151 facility: Ospedale San Luca - U.O. Utic - Cardiologia status: RECRUITING city: Vallo Della Lucania state: SA zip: 84078 country: Italy name: ANTONIO ALOIA, MD role: CONTACT lat: 40.22786 lon: 15.26635 facility: Aou Senese Ospedale S. Maria Alle Scotte - Cardiologia status: RECRUITING city: Siena state: SI zip: 53100 country: Italy name: SERAFINA VALENTE, MD role: CONTACT lat: 43.31822 lon: 11.33064 facility: Ospedale San Bartolomeo - Sc Riabilitazione Cardiologica status: RECRUITING city: Sarzana state: SP zip: 19038 country: Italy name: DANIELE BERTOLI, MD role: CONTACT lat: 44.11178 lon: 9.9622 facility: P.O. Lentini - Uosd Di Cardiologia Con Utic status: RECRUITING city: Lentini state: SR zip: 96016 country: Italy name: VINCENZO CRISCI, MD role: CONTACT lat: 37.28556 lon: 14.99737 facility: Ospedale Ss. Annunziata - Cardiologia Clinica Ed Interventistica status: RECRUITING city: Sassari state: SS zip: 07100 country: Italy name: GAVINO CASU, MD role: CONTACT lat: 40.72586 lon: 8.55552 facility: Po Ponente - Ospedale Santa Corona - Sc Cardiologia Ponente status: RECRUITING city: Pietra Ligure state: SV zip: 17027 country: Italy name: CHIARA BERNELLI, MD role: CONTACT lat: 44.1492 lon: 8.28206 facility: Casa Di Cura Villa Verde - Cardiologia status: RECRUITING city: Taranto state: TA zip: 74100 country: Italy name: ANNA N JOHN, MD role: CONTACT lat: 40.46435 lon: 17.24707 facility: Osp. San Pancrazio-Santo Stefano - Riabilitazione Cardiologica status: RECRUITING city: Arco state: TN zip: 38062 country: Italy name: GIOVANNI CIOFFI, MD role: CONTACT lat: 45.91772 lon: 10.88672 facility: Ospedale Santa Chiara - Divisione Di Cardiologia status: RECRUITING city: Trento state: TN zip: 38122 country: Italy name: FILIPPO ZILIO, MD role: CONTACT lat: 46.06787 lon: 11.12108 facility: Por Cirie' Lanzo Presidio Cirie' - S.C. Cardiologia status: RECRUITING city: Ciriè state: TO zip: 10073 country: Italy name: Michele Capriolo, MD role: CONTACT lat: 45.23486 lon: 7.60125 facility: Aou San Luigi Gonzaga - S.C.D.O. Cardiologia status: RECRUITING city: Orbassano state: TO zip: 10043 country: Italy name: Carloalberto Biolù, MD role: CONTACT lat: 45.00547 lon: 7.53813 facility: Casa Di Cura Villa Serena - Riabilitazione Cardiorespiratoria status: RECRUITING city: Piossasco state: TO zip: 10045 country: Italy name: ALEX MICANTI, MD role: CONTACT lat: 44.98802 lon: 7.4601 facility: Ospedale Degli Infermi - Sc Cardiologia status: RECRUITING city: Rivoli state: TO zip: 10098 country: Italy name: EMANUELE TIZZANI, MD role: CONTACT lat: 45.07073 lon: 7.51465 facility: Ospedale San Giovanni Bosco - Sc Cardiologia status: RECRUITING city: Torino state: TO zip: 10154 country: Italy name: MAURIZIO BERTAINA, MD role: CONTACT lat: 45.07049 lon: 7.68682 facility: Casa Di Cura Pineta Del Carso - U.O. Riabilitazione Cardiologica status: RECRUITING city: Aurisina state: TS zip: 34011 country: Italy name: LARA GOMBAC, MD role: CONTACT lat: 45.74968 lon: 13.67345 facility: Asugi Trieste - Sc Patologie Cardiovascolari status: RECRUITING city: Trieste state: TS zip: 34125 country: Italy name: LUISA MATTEI, MD role: CONTACT lat: 45.64953 lon: 13.77679 facility: Pou "Santa Maria Della Misericordia" - S.O.C. Cardiologia status: RECRUITING city: Udine state: UD zip: 33100 country: Italy name: MARIZA DE BIASIO, MD role: CONTACT lat: 46.0693 lon: 13.23715 facility: Ospedale Multimedica Castellanza - Cardiologia status: RECRUITING city: Castellanza state: VA zip: 21053 country: Italy name: ANNA PICOZZI, MD role: CONTACT lat: 45.61079 lon: 8.89616 facility: Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia status: RECRUITING city: Saronno state: VA zip: 21047 country: Italy name: DANIELE NASSIACOS, MD role: CONTACT lat: 45.62513 lon: 9.03517 facility: Ospedale Di Circolo Galmarini - Cardiologia status: NOT_YET_RECRUITING city: Tradate state: VA zip: 21049 country: Italy name: MASSIMO BIGNOTTI, MD role: CONTACT lat: 45.70843 lon: 8.90763 facility: Ospedale Sant'Andrea - Sc Cardiologia status: RECRUITING city: Vercelli state: VC zip: 13100 country: Italy name: MARIA BERTOLAZZI, MD role: CONTACT lat: 45.32163 lon: 8.41989 facility: Ospedale Dell'Angelo - U.O.C. Cardiologia status: RECRUITING city: Mestre state: VE zip: 30171 country: Italy name: SAKIS THEMISTOCLAKIS, MD role: CONTACT lat: 45.49167 lon: 12.24538 facility: Policlinico San Marco - Riabilitazione Cardiologica status: RECRUITING city: Mestre state: VE zip: 30173 country: Italy name: FRANCO DEL PICCOLO, MD role: CONTACT lat: 45.49167 lon: 12.24538 facility: Ospedale P.F. Calvi - Uos Di Cardiologia Riabilitativa status: RECRUITING city: Noale state: VE zip: 30033 country: Italy name: VALENTINA PESCATORE, MD role: CONTACT lat: 45.54596 lon: 12.06445 facility: Ospedale Civile - U.O.C. Di Cardiologia status: NOT_YET_RECRUITING city: San Dona' Di Piave state: VE zip: 30027 country: Italy name: LEONARDO DI ASCENZO, MD role: CONTACT lat: 45.63019 lon: 12.5681 facility: Ospedale Civile - U.O.C. Di Cardiologia status: RECRUITING city: Arzignano state: VI zip: 36071 country: Italy name: CLAUDIO BILATO, MD role: CONTACT lat: 45.52027 lon: 11.33446 facility: Ospedale Alto Vicentino - U.O.C. Cardiologia - Ucic status: RECRUITING city: Santorso state: VI zip: 36014 country: Italy name: GIOVANNI MORANI, MD role: CONTACT lat: 45.73383 lon: 11.38785 facility: Ospedale Civile San Bortolo - U.O.C. Cardiologia status: RECRUITING city: Vicenza state: VI zip: 36100 country: Italy name: VALENTINA SIVIERO, MD role: CONTACT lat: 45.54672 lon: 11.5475 facility: Irccs Ospedale Sacro Cuore Don Calabria - U.O. Di Cardiologia status: RECRUITING city: Negrar state: VR zip: 37024 country: Italy name: GIULIO MOLON, MD role: CONTACT lat: 45.52918 lon: 10.93899 facility: Ospedale G. Fracastoro - U.O.C. Di Cardiologia status: RECRUITING city: San Bonifacio state: VR zip: 37047 country: Italy name: MAURIZIO ANSELMI, MD role: CONTACT lat: 45.39595 lon: 11.27352 facility: Aoui Di Verona - U.O. Cardiologia status: RECRUITING city: Verona state: VR zip: 37126 country: Italy name: MARIA G GASPARI, MD role: CONTACT lat: 45.4299 lon: 10.98444 facility: Ospedale Belcolle - Uoc Cardiologia Ed Emodinamica status: RECRUITING city: Viterbo state: VT zip: 01100 country: Italy name: LUIGI SOMMARIVA, MD role: CONTACT lat: 42.41937 lon: 12.1056 facility: Ospedale Ss. Trinita' - S.C. Di Cardiologia status: RECRUITING city: Borgomanero zip: 28021 country: Italy name: PIERFRANCO S DELLAVESA, MD role: CONTACT lat: 45.69873 lon: 8.4623 facility: Istituti Clinici Scientifici Maugeri Irccs Sede Di Veruno - Uo Cardiologia Riabilitativa status: RECRUITING city: Gattico zip: 28013 country: Italy name: MASSIMO PISTONO, MD role: CONTACT lat: 45.70717 lon: 8.52003 facility: Presidio Ospedaliero San Giugliano - U.O. Cardiologia - Utic status: RECRUITING city: Giugliano in Campania zip: 80014 country: Italy name: GIOVANNI NAPOLITANO, MD role: CONTACT lat: 40.92849 lon: 14.20197 facility: Ospedale Madonna Delle Grazie - Ssd Utic status: NOT_YET_RECRUITING city: Matera zip: 75100 country: Italy name: MICHELE A CLEMENTE, MD role: CONTACT lat: 40.66599 lon: 16.60463 facility: Ospedale Buon Consiglio Fatebenefratelli - U.O.Complessa Di Cardiologia E Utic status: RECRUITING city: Napoli zip: 80123 country: Italy name: GAETANO M RUOCCO, MD role: CONTACT lat: 40.85216 lon: 14.26811 facility: Aorn Cardarelli - U.O. Cardiologia Con Utic status: RECRUITING city: Napoli zip: 80131 country: Italy name: CIRO MAURO, MD role: CONTACT lat: 40.85216 lon: 14.26811 facility: Aorn Ospedale Dei Colli - P.O. Monaldi - Uosd Malattie Cardiologiche Congenite Adulti-Guch status: RECRUITING city: Napoli zip: 80131 country: Italy name: BERARDO SARUBBI, MD role: CONTACT lat: 40.85216 lon: 14.26811 facility: Ospedale Dei Pellegrini - Uoc Cardiologia-Utic status: NOT_YET_RECRUITING city: Napoli zip: 80134 country: Italy name: GIUSEPPE BRUZZESE, MD role: CONTACT lat: 40.85216 lon: 14.26811 facility: Ospedale S. Giovanni Bosco - Sc Cardiologia - Utic status: RECRUITING city: Napoli zip: 80134 country: Italy name: PAOLO TAMMARO, MD role: CONTACT lat: 40.85216 lon: 14.26811 facility: Ospedale Del Mare - U.O. Cardiologia Con Utic-Emodinamica status: RECRUITING city: Napoli zip: 80147 country: Italy name: BERNARDINO TUCCILLO, MD role: CONTACT lat: 40.85216 lon: 14.26811 facility: Aou Maggiore Della Carita' - Scdo Cardiologia Ii status: RECRUITING city: Novara zip: 28100 country: Italy name: LIDIA ROSSI, MD role: CONTACT lat: 45.44694 lon: 8.62118 facility: Clinica San Gaudenzio - Uoa Cardiologia status: RECRUITING city: Novara zip: 28100 country: Italy name: NADIA PODIMANI, MD role: CONTACT lat: 45.44694 lon: 8.62118 facility: Ospedale Santa Maria Delle Grazie - U.O. Cardiologia - Utic Con Emodinamica status: NOT_YET_RECRUITING city: Pozzuoli zip: 80078 country: Italy name: GIANLUIGI TAGLIAMONTE, MD role: CONTACT lat: 40.84394 lon: 14.0952 facility: Ospedale Mauriziano Umberto I - Sc Cardiologia status: RECRUITING city: Torino zip: 10128 country: Italy name: Giuseppe Musumeci, MD role: CONTACT lat: 45.07049 lon: 7.68682 hasResults: False
<|newrecord|> nctId: NCT06275100 id: HUTH briefTitle: PREhabilitation in Patients Awaiting Acute Inpatient Cardiac SurgEry acronym: (PREP-ACE) overallStatus: RECRUITING date: 2024-04-03 date: 2024-12 date: 2025-06 date: 2024-02-23 date: 2024-04-09 name: University of Hull class: OTHER briefSummary: This is a single centre, single arm pilot feasibility study to determine the feasibility and practicality of prehabilitation in acute inpatients waiting for cardiac surgery. We will be looking into participant eligibility, acceptability, recruitment rates, completion rates and barriers to implementing a prehabilitation programme. Secondary outcomes include safety (incidence of adverse events directly related to the study), improvement in 6 minutes walk test (6MWT), hand grip strength, quality of life, and spirometry. At the end of the trial, we will be seeking the feedback of the participants to help us improve the design further. conditions: Cardiac Disease conditions: Aortic Valve Disease conditions: Coronary Artery Disease conditions: Endocarditis conditions: Valve Heart Disease studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: Single arm pilot feasibility study in acute inpatients waiting for cardiac surgery. Intervention is a prehabilitation program primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 20 type: ESTIMATED name: Prehabilitation measure: Feasibility of prehabilitation in acute inpatients waiting for cardiac surgery measure: Efficacy of prehabilitation measure: Efficacy of prehabilitation measure: Efficacy of prehabilitation measure: Efficacy of prehabilitation measure: Efficacy of prehabilitation measure: Complication rate measure: Safety of Prehabilitation in acute inpatients waiting for surgery sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Hull University Teaching Hospital status: RECRUITING city: Hull zip: HU1 3DR country: United Kingdom lat: 53.7446 lon: -0.33525 typeAbbrev: Prot hasProtocol: True hasSap: False hasIcf: False label: Study Protocol date: 2023-11-06 uploadDate: 2024-02-15T17:59 filename: Prot_000.pdf size: 146015 typeAbbrev: ICF hasProtocol: False hasSap: False hasIcf: True label: Informed Consent Form date: 2023-11-06 uploadDate: 2024-02-15T18:01 filename: ICF_001.pdf size: 107547 hasResults: False
<|newrecord|> nctId: NCT06275087 id: situm1phd briefTitle: Differences in Speed of Recovery From Anesthesia for Intraoral Surgery acronym: PSIOS overallStatus: RECRUITING date: 2024-04-10 date: 2026-03 date: 2026-07 date: 2024-02-23 date: 2024-04-22 name: Clinical Hospital Centre Zagreb class: OTHER briefSummary: The goal of this clinical trial is to compare two groups of patients going in general anesthesia for intraoral surgery, the first group TIVA with propofol and the second group inhalational with sevoflurane. The main questions it aims to answer are to asses speed and quality of recovery from general anesthesia.
Participants will fill out a questionnaire to evaluate the quality of recovery from anesthesia using the QoR-40 1h, 24h, and 30 days after waking up from anesthesia in comparison to the results of the same questionnaire before surgery. Also, the investigators will perform a hand grip and bite strength test on the patients after waking up from anesthesia in the operating room, after 1 hour in the recovery room, and after 24 hours compared to preoperative values.
The investigators will compare TIVA and Volatile groups to see if there are any differences in recovery seed, muscle strength recovery, postoperative nausea and vomiting, and shivering between groups. conditions: Intraoral Tumor studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: TRIPLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 42 type: ESTIMATED name: Propofol name: Sevoflurane measure: "Quality of recovery from anesthesia" QoR-40 questionnaire measure: bite strength and hand grip strength measure: Postoperative nausea and vomiting measure: Postoperative shivering sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University Hospital Centre Zagreb status: RECRUITING city: Zagreb zip: 10000 country: Croatia name: Ivan Šitum role: CONTACT phone: 0915143620 email: ivsitum@gmail.com name: Ivan Šitum role: PRINCIPAL_INVESTIGATOR lat: 45.81444 lon: 15.97798 hasResults: False
<|newrecord|> nctId: NCT06275074 id: 23-007716 briefTitle: Dry Needling and Therapeutic Exercise on Sleep in Individuals With Chronic Neck Pain and Sleep Disturbance overallStatus: RECRUITING date: 2024-03-14 date: 2024-09-01 date: 2025-03-01 date: 2024-02-23 date: 2024-04-05 name: Mayo Clinic class: OTHER briefSummary: Feasibility study investigating the effects of dry needling on individuals with chronic neck pain and sleep disturbance. conditions: Neck Pain conditions: Sleep Disturbance studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: SINGLE maskingDescription: Outcome assessors will be blinded to group assignment of participants. whoMasked: OUTCOMES_ASSESSOR count: 28 type: ESTIMATED name: Dry Needling name: Therapeutic Exercise measure: Participant retention rate measure: Participant intervention adherence measure: Number of adverse responses to treatment measure: Sleep Duration measure: Sleep Quality measure: Disability Level measure: Pain Level sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Mayo Clinic - Motion Analysis Lab status: RECRUITING city: Rochester state: Minnesota zip: 55905 country: United States name: Ray Lunasin role: CONTACT phone: 507-538-0839 email: lunasin.ray@mayo.edu lat: 44.02163 lon: -92.4699 hasResults: False
<|newrecord|> nctId: NCT06275061 id: KY-2020-021 briefTitle: Chinese Obesity and MEtabolic Surgery Database (COMES Database) acronym: COMES overallStatus: RECRUITING date: 2020-05-01 date: 2030-12-31 date: 2040-12-31 date: 2024-02-23 date: 2024-02-23 name: Jinan University Guangzhou class: OTHER name: Chinese Obesity and Metabolic Surgery Collaborative briefSummary: The purpose of the Chinese Obesity and MEtabolic Surgery Database (COMES Database) is to collect data and examine the long-term effects of metabolic and bariatric surgery on obesity and metabolic disorders in the Chinese population. conditions: Obesity conditions: Metabolic Surgery conditions: Bariatric Surgery conditions: Weight Loss studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 1000000 type: ESTIMATED name: Metabolic and Bariatric Surgery measure: Excess weight loss effect of metabolic and bariatric surgery after 1 year measure: Excess weight loss effect of metabolic and bariatric surgery in long-term follow-ups measure: Excess weight loss effect of metabolic and bariatric surgery in long-term follow-ups measure: Excess weight loss effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery after 1 year measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery after 1 year measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery after 1 year measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery after 1 year measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups measure: Adverse events rate of metabolic and bariatric surgery sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: The First Affiliated Hospital of Jinan University status: RECRUITING city: Guangzhou state: Guangdong zip: 510630 country: China name: Wah Yang, MD role: CONTACT phone: +8615920373823 email: yangwah@qq.com lat: 23.11667 lon: 113.25 hasResults: False
<|newrecord|> nctId: NCT06275048 id: STUDY00006302 briefTitle: The Influence of Oral Contraceptives During Disuse overallStatus: RECRUITING date: 2024-01-26 date: 2024-12 date: 2025-05 date: 2024-02-23 date: 2024-02-23 name: University of Central Florida class: OTHER briefSummary: Studies across various sports and physical activities have consistently shown that females incur more injuries compared to their male counterparts, but the underlying reasons for this disparity remain poorly understood. While differences in hormone levels between males and females have been speculated to play a role, very little rigorous research has been conducted to directly examine potential connections between sex hormones and injury risk. Specifically, females have been shown to be at greater risk for hand and wrist injuries. The higher injury incidence begins at puberty and persists across the lifespan, suggesting a link to hormonal factors. However, significant gaps remain in understanding the relationships between the menstrual cycle, exogenous hormones from birth control, and risk factors for sports-related injury in females. The purpose of this study is to examine changes in muscle strength and neuromuscular activation among females using monophasic oral contraceptives, females not using oral contraceptives, and males during one week of wrist/hand immobilization. conditions: Oral Contraceptives conditions: Rehabilitation conditions: Menstrual Cycle conditions: Physical Therapy studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: BASIC_SCIENCE masking: NONE count: 60 type: ESTIMATED name: Wrist/hand immobilization measure: Grip Strength measure: Muscle activation sex: ALL minimumAge: 18 Years maximumAge: 35 Years stdAges: ADULT facility: University of Central Florida status: RECRUITING city: Orlando state: Florida zip: 32816 country: United States name: Matt S Stock, Ph.D. role: CONTACT phone: 407-823-0364 email: matt.stock@ucf.edu name: Matt S Stock, Ph.D. role: PRINCIPAL_INVESTIGATOR lat: 28.53834 lon: -81.37924 hasResults: False
<|newrecord|> nctId: NCT06275035 id: 4235 briefTitle: Evaluation of Memantine in the Preservation of Memory and Neurocognition Following CSI acronym: MEMENTO overallStatus: RECRUITING date: 2024-02-22 date: 2026-01 date: 2031-01 date: 2024-02-23 date: 2024-03-01 name: Tata Memorial Centre class: OTHER briefSummary: The goal of this clinical trial is to evaluate the role of memantine in preservation of memory and neurocognition in patients undergoing craniospinal irradiation. Participants will be randomised into two arms and the interventional arm will receive memantine along with the standard treatment. Researchers will compare the neurocognitive tests of participants in both the arms to see if memantine leads to significant preservation of memory and cognition post radiation therapy. conditions: Neurocognitive Dysfunction studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: NONE count: 101 type: ESTIMATED name: Memantine Oral Tablet measure: Cognitive-deterioration-free survival at 2 years measure: Full-Scale Intelligence Quotient (FSIQ) in children measure: Overall survival (OS) measure: Academic performance by scholastic performance and grades measure: Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] of Memantine measure: Progression-Free Survival (PFS) measure: Full-Scale Intelligence Quotient (FSIQ) in adults measure: Full Scale Intelligence Quotient change in subgroups measure: Radiological features of cognitive decline on Magnetic Resonance Imaging measure: Neuroinflammatory markers correlation with neurocognitive decline and survival sex: ALL minimumAge: 5 Years maximumAge: 39 Years stdAges: CHILD stdAges: ADULT facility: Tata Memorial Hospital status: RECRUITING city: Mumbai state: Maharashtra zip: 400012 country: India name: Dr Tejpal Gupta, MD role: CONTACT phone: 022-24177000 phoneExt: 6015 email: tejpalgupta@rediffmail.com lat: 19.07283 lon: 72.88261 hasResults: False
<|newrecord|> nctId: NCT06275022 id: NanjingCH011665 briefTitle: A Prospective Study on the Treatment of cLM Based on ICG Imaging overallStatus: RECRUITING date: 2023-01-01 date: 2025-12-31 date: 2026-06-30 date: 2024-02-23 date: 2024-02-23 name: Nanjing Children's Hospital class: OTHER briefSummary: The goal of this prospective randomized controlled study is to explore the role of indocyanine green-fluorescence imaging in management of cystic lymphatic malformation.. To clarify the application value of indocyanine green-fluorescence imaging in both diagnosis and treatment of cystic lymphatic malformation (cLM) in children, is helpful for exploring pathogenesis of cLM, and providing a clearer scientific basis for subsequent surgical intervention. It also provides alternative for the future diagnosis and treatment of cLM.
Participants will receive indocyanine green-fluorescence imaging before operation, while the patients in control group will receive traditional operation.
Researchers will compare difference in curative effect between two groups. conditions: Lymphatic Malformation studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 110 type: ESTIMATED name: Inflow occlusion with perforation of septation and sclerotherapy name: Perforation of septation and sclerotherapy name: Indocyanine green-guided partial resection and sclerotherapy name: Partial resection and sclerotherapy measure: Cure rate measure: Effective rate measure: Treatment frequency measure: Likert score measure: Wound infection measure: Delayed healing measure: Pigmentation sex: ALL minimumAge: 30 Days maximumAge: 16 Years stdAges: CHILD facility: Children's hospital of Nanjing medical university status: RECRUITING city: Nanjing state: Jiangsu zip: 210008 country: China name: Tao Han, Dr. role: CONTACT phone: +86 186 5190 3495 email: dr.hantao@njmu.edu.cn lat: 32.06167 lon: 118.77778 hasResults: False
<|newrecord|> nctId: NCT06275009 id: 2023-1990 briefTitle: Chinese Occupational Population Cohort of Lifestyle and Physical Fitness (LiFitChina) acronym: LiFitChina overallStatus: RECRUITING date: 2023-12-11 date: 2026-12-11 date: 2026-12-11 date: 2024-02-23 date: 2024-02-28 name: China National Center for Cardiovascular Diseases class: OTHER_GOV briefSummary: The incidence and prevalence of metabolic risk factors such as obesity, hypertension, diabetes, and dyslipidemia, as well as cardiovascular diseases (CVD), are continuously rising among the occupational population in China, primarily comprising the middle-aged and young adults. Unhealthy lifestyles and declining physical fitness are independent risk factors affecting cardiovascular health. Additionally, the level of physical fitness is influenced by postnatal lifestyles. Lifestyle factors related to cardiovascular health in the occupational population encompass various aspects, including smoking, physical activity, diet, sleep, psychological stress, etc. These factors may interact or have a synergistic effect, necessitating a comprehensive assessment.
This project proposes a prospective cohort study design to establish a monitoring cohort for lifestyle and physical fitness among the occupational population. The study will track and follow individuals with or without any CVD metabolic risk factors, collecting information on general status, lifestyle, physical fitness, and health examination data. Exposure factors such as lifestyle and physical fitness will be measured annually, and the occurrence of CVD-related health outcomes will be observed. The aim is to develop a comprehensive evaluation index for cardiovascular health lifestyle, analyze the direct and indirect impacts of lifestyle and physical fitness on the occurrence and development of CVD, and explore potential mediating and moderating effects of physical fitness in the association between lifestyle and cardiovascular health. conditions: Lifestyle conditions: Physical Fitness conditions: Cardiovascular Diseases studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 18512 type: ESTIMATED measure: the composite end point of new major adverse cardiovascular events measure: new incidence of each major adverse cardiovascular events measure: new incidence of cancer measure: new incidence of all-cause death measure: level of systolic pressure measure: level of diastolic pressure measure: level of blood lipid measure: level of BMI measure: level of maximal oxygen uptake (VO2max) measure: level of metabolic equivalents (METs) sex: ALL minimumAge: 18 Years maximumAge: 59 Years stdAges: ADULT facility: Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College status: RECRUITING city: Beijing state: Beijing country: China name: Xue Feng, MD PhD role: CONTACT phone: +86-15601378512 email: 29611290@qq.com lat: 39.9075 lon: 116.39723 hasResults: False
<|newrecord|> nctId: NCT06274996 id: 2024ZSLYEC-063 briefTitle: Efficacy and Safety Analysis of Upadacitinib in Inflammatory Bowel Disease overallStatus: COMPLETED date: 2021-01-01 date: 2023-12-31 date: 2023-12-31 date: 2024-02-23 date: 2024-02-23 name: Sixth Affiliated Hospital, Sun Yat-sen University class: OTHER briefSummary: This study focuses on evaluating Upadacitinib, a new oral medication that inhibits specific enzymes involved in inflammation, for treating inflammatory bowel disease (IBD), which includes conditions such as Crohn\&#39;s Disease and Ulcerative Colitis. The goal is to determine how effective and safe this drug is for patients in China, where data is currently lacking.IBD significantly affects individuals\&#39; quality of life and imposes a high burden on society and healthcare systems. Current treatments don\&#39;t work for everyone, and some patients may need surgery. Upadacitinib has shown promise in other countries for treating IBD and related conditions and has been approved by the US FDA for such use.
Our study is retrospective and multicenter, meaning it will look back at patient records from multiple hospitals to analyze the outcomes of those who have received Upadacitinib. Investigators aim to enroll patients treated between January 2020 and December 2023, focusing on adults who have taken Upadacitinib for at least 8 weeks.For patients, families, and healthcare providers, this research could mean a potential new treatment option for IBD. Understanding Upadacitinib\&#39;s efficacy and safety could lead to better management of the disease, possibly reducing the need for surgery and improving the quality of life for those affected by IBD. The ultimate goal is to provide more personalized and effective treatment strategies for IBD patients in China. conditions: Inflammatory Bowel Diseases studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 81 type: ACTUAL name: Upadacitinib measure: Steroid-Free Clinical Remission measure: Clinical Response measure: Endoscopic Remission measure: Mucosal Healing measure: Radiological remission measure: Radiological response sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: the Sixth Affiliated Hospital of Sun Yat-Sen University city: Guangzhou state: Guangdong zip: 510655 country: China lat: 23.11667 lon: 113.25 hasResults: False
<|newrecord|> nctId: NCT06274983 id: SCH-2629 briefTitle: DMD- Interactive Virtual Reality Study acronym: DMD-IVR overallStatus: ACTIVE_NOT_RECRUITING date: 2023-04-20 date: 2024-02-29 date: 2024-02-29 date: 2024-02-23 date: 2024-02-26 name: Sheffield Children's NHS Foundation Trust class: OTHER name: National Institute for Health Research, United Kingdom name: Sheffield Hallam University name: UCL Great Ormond Street Institute of Child Health name: Leeds General Infirmary briefSummary: This study will help determine if an Interactive Virtual Reality system can improve the physiotherapy of young patients with Duchenne muscular dystrophy (DMD). conditions: Duchenne Muscular Dystrophy studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 14 type: ACTUAL name: IVR platform trial measure: Compliance: Ratings of frequency of the DMD-IVR device use for the participant's to complete recommended physiotherapy exercises. measure: Compliance: Ratings of duration of the DMD-IVR device use for the participant's to complete recommended physiotherapy exercises. measure: Post-trial qualitative interviews on perceptions, acceptability, usability and effectiveness of DMD-IVR device in the context of the family's overall burden of care measure: DMD-IVR Effectiveness standard functional assessments: North Star Ambulatory Assessment (NSAA) measure: DMD-IVR effectiveness measures with a Timed test 4 stair climb measure: DMD-IVR effectiveness measured joint range of movement using Goniometer (Standard BASELINE® 12-inch) sex: ALL minimumAge: 5 Years maximumAge: 10 Years stdAges: CHILD facility: Sheffield Childrens NHS FT city: Sheffield state: South Yorkshire zip: S10 2TH country: United Kingdom lat: 53.38297 lon: -1.4659 hasResults: False
<|newrecord|> nctId: NCT06274970 id: 2022-143-Mch-EXP-50 briefTitle: PaThERAS: ERAS Protocols in Thyroid & Parathyroid Surgery acronym: PaThERAS overallStatus: RECRUITING date: 2023-01-25 date: 2024-09-25 date: 2024-09-25 date: 2024-02-23 date: 2024-02-23 name: Sanjay Gandhi Postgraduate Institute of Medical Sciences class: OTHER_GOV briefSummary: Enhanced recovery after surgery protocols are evidence-based multidisciplinary programs implemented in the perioperative setting to improve postoperative recovery and attenuate the surgical stress response. They have been used with success after many different types of surgery to improve perioperative patient outcomes. However, evidence on their effectiveness in thyroid and parathyroid surgery remains sparse. Goal of PaThERAS study is to investigate the clinical benefits and cost-effectiveness of enhanced recovery protocols for the perioperative management in patients undergoing total thyroidectomy for large goiters/ cancers and parathyroidectomy for symptomatic hyperparathyroidism in non-day-care setting. conditions: Thyroid Diseases conditions: Parathyroid Diseases conditions: ERAS studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 110 type: ESTIMATED name: Enhanced recovery protocols name: Conventional Protocols measure: To compare the rate of hypocalcemia in patients undergoing thyroid and parathyroid surgery implementing Enhanced recovery after surgery protocols vs Conventional peri operative protocols measure: To compare length of hospital stay in patients undergoing thyroid and parathyroid surgery in days measure: To compare hospital costs in patients undergoing thyroid and parathyroid surgery implementing Enhanced recovery after surgery protocols vs Conventional peri operative protocols measure: To compare postoperative complication rates in patients undergoing thyroid and parathyroid surgery implementing Enhanced recovery after surgery protocols vs Conventional peri operative protocols measure: To compare readmission rate sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Sanjay Gandhi Post Graduate Institute of Medical Sciences status: RECRUITING city: Lucknow state: Uttar Pradesh zip: 226014 country: India name: Gaurav Agarwal role: CONTACT phone: 8004904646 email: gauravbsi@gmail.com name: Rinelle Mascarenhas role: CONTACT phone: 8004904653 email: rmasky@hotmail.com name: Gaurav Agarwal, MS role: PRINCIPAL_INVESTIGATOR name: Rinelle Mascarenhas, DNB General Surgery role: SUB_INVESTIGATOR lat: 26.83928 lon: 80.92313 hasResults: False
<|newrecord|> nctId: NCT06274957 id: SaglikBilimleriUN briefTitle: The Effect of Airway and Chest Wall Oscillation on Respiratory Functions in COPD Patients in Acute Exacerbation overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2024-05-07 date: 2024-06-01 date: 2024-02-23 date: 2024-04-17 name: Saglik Bilimleri Universitesi class: OTHER name: Gulhane Training and Research Hospital briefSummary: Chronic obstructive pulmonary disease (COPD); It is a common, treatable and preventable disease characterized by progressive and irreversible airflow limitation and has systemic effects with respiratory system involvement. Increased respiratory workload, decreased work . conditions: COPD Exacerbation Acute studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: PARTICIPANT count: 27 type: ESTIMATED name: CONTROL name: PEP DEVICE name: HFCWO DEVICE measure: COPD assessment test measure: Clinical COPD Questionnaire measure: mMRC dyspnea scale measure: Richard-Campbell Sleep Questionnaire measure: 30 second sit and stand measure: BODE index measure: chest circumference measurements measure: Modified Borg Scale measure: muscle strenght test sex: ALL minimumAge: 40 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Health Sciences city: Istanbul zip: 34353 country: Turkey name: ZUHAL KUNDURACILAR PROF DR role: CONTACT phone: +90 530 219 5286 email: zuhal.kunduracilar@sbu.edu.tr name: GAMZE KOYUTÜRK PT, PhD(c) role: CONTACT phone: +90 5065798671 email: gamzealtinkaynak@gmail.com name: GAMZE KOYUTÜRK PT, PhD (C) role: PRINCIPAL_INVESTIGATOR lat: 41.01384 lon: 28.94966 hasResults: False
<|newrecord|> nctId: NCT06274944 id: PEDS-2023-31694 briefTitle: Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study overallStatus: RECRUITING date: 2024-02-12 date: 2025-01-31 date: 2025-01-31 date: 2024-02-23 date: 2024-03-04 name: University of Minnesota class: OTHER briefSummary: This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants. conditions: Premature Birth studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 30 type: ESTIMATED name: nasogastric tube placement pH confirmation device measure: PH reading comparison sex: ALL maximumAge: 2 Years stdAges: CHILD facility: University of Minnesota status: RECRUITING city: Minneapolis state: Minnesota zip: 55414 country: United States name: Brittany Faanes role: CONTACT lat: 44.97997 lon: -93.26384 hasResults: False
<|newrecord|> nctId: NCT06274931 id: 373 briefTitle: Analysis of the Pulmonary Microbiome overallStatus: RECRUITING date: 2024-02-01 date: 2024-02-20 date: 2024-06-20 date: 2024-02-23 date: 2024-02-23 name: University Magna Graecia class: OTHER briefSummary: The purpose of the protocol is to study the pulmonary microbiome in patients who develop pneumonia. conditions: Pneumonia conditions: Microbial Colonization conditions: Microbial Disease studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: PROSPECTIVE count: 30 type: ESTIMATED name: Bronchoscopy measure: Assessment of Lung Microbiome in Acute Respiratory Failure sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University Hosp[ital status: RECRUITING city: Catanzaro zip: 88100 country: Italy name: Andrea Bruni role: CONTACT phone: 3401414553 email: andreabruni@unicz.it lat: 38.88247 lon: 16.60086 hasResults: False
<|newrecord|> nctId: NCT06274918 id: 202111418 briefTitle: Reducing ESKAPE Transmission in the Operating Room overallStatus: RECRUITING date: 2023-02-01 date: 2024-06-01 date: 2024-12-01 date: 2024-02-23 date: 2024-02-23 name: University of Iowa class: OTHER name: RDB Bioinformatics, LLC name: Georgia-Pacific briefSummary: This study is designed to examine the impact of a personalized, body worn alcohol dispenser on the epidemiology of ESKAPE transmission in the anesthesia work area for patients undergoing surgery requiring general anesthesia. conditions: Surgical Procedure, Unspecified studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 40 type: ESTIMATED name: Personalized Body-Worn Alcohol Dispenser measure: ESKAPE transmission events with and without the body worn device measure: The epidemiology of ESKAPE transmission events measure: The epidemiology of ESKAPE transmission events measure: The epidemiology of ESKAPE transmission events measure: The epidemiology of ESKAPE transmission events measure: The epidemiology of ESKAPE transmission events measure: 90-Day Healthcare-Associated Infections sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Iowa status: RECRUITING city: Iowa City state: Iowa zip: 52242 country: United States name: Randy W Loftus, MD role: CONTACT lat: 41.66113 lon: -91.53017 hasResults: False
<|newrecord|> nctId: NCT06274905 id: 160123 briefTitle: Topical Anaesthesia in Cutaneous Head and Neck Surgery overallStatus: COMPLETED date: 2023-02-20 date: 2023-07-07 date: 2023-07-07 date: 2024-02-23 date: 2024-02-23 name: University Hospital Waterford class: OTHER briefSummary: This study aims to assess if EMLA or ethyl chloride spray are effective in reducing the pain associated with local anaesthetic administration in cutaneous surgery of the head and neck compared to a placebo and control group through a randomized control trial study design. conditions: Pain, Acute conditions: Head and Neck Cancer conditions: Cutaneous Tumor studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: SEQUENTIAL primaryPurpose: TREATMENT masking: SINGLE maskingDescription: Single blinding (for participants) only for patients receiving EMLA or EMLA placebo. whoMasked: PARTICIPANT count: 124 type: ACTUAL name: EMLA name: Ethyl chloride name: Aqueous cream BP measure: Pain score measure: Patient satisfaction sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University Hospital Waterford city: Waterford zip: X91 ER8E country: Ireland lat: 52.25833 lon: -7.11194 typeAbbrev: Prot_SAP hasProtocol: True hasSap: True hasIcf: False label: Study Protocol and Statistical Analysis Plan date: 2022-12-20 uploadDate: 2024-02-06T12:37 filename: Prot_SAP_000.pdf size: 417714 hasResults: False
<|newrecord|> nctId: NCT06274892 id: 23-5818 briefTitle: Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process acronym: PROMOTE overallStatus: RECRUITING date: 2024-04-01 date: 2024-08-31 date: 2024-11-30 date: 2024-02-23 date: 2024-04-17 name: University Health Network, Toronto class: OTHER briefSummary: Radiation therapy (RT) is a key component in the treatment of breast and prostate cancer. However, patients may experience significant side effects. Patients can accurately self-report side effects from RT and these patient-reported outcomes (PROs) can direct communication between patient and healthcare provider (HCP), and facilitate joint decision making.
Patients state that using mobile phone applications (apps) to collect PROs (mPROs) is easily incorporated into their daily routines, allowing them to engage at a time and pace that suits them. When mPRO collection is combined with remote symptom monitoring by HCPs, these systems result in improvements in symptom control and quality of life.
Currently, patients receiving RT are seen by a Radiation Oncologist once per week during RT and once every few months after RT has finished. Recent evaluations indicate that patients and physicians consider the number of visits to be too frequent during RT, and too infrequent immediately after RT. This research will use weekly mPROs (remotely monitored by RT HCP) to determine if a patient needs (or wants) to be seen by a RT HCP during and/or immediately after RT.
Using mPROs to optimize RT patient assessment processes will ensure patients are seen if and when required. For a patient, this could result in reduced time and costs at the hospital. For the physician, resources could be re-allocated to improve access to RT services. Using mPROs after RT has the potential for earlier treatment of side effects, which has been linked to improved survival and quality of life. conditions: Prostate Cancer conditions: Breast Cancer studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 124 type: ESTIMATED name: Remote monitoring PROs measure: Remote monitoring efficiency measure: Remote monitoring efficacy measure: Remote monitoring value measure: Remote monitoring comprehensiveness measure: Influencing factors (patient) measure: Influencing factors (disease) measure: Influencing factors (treatment) measure: Influencing factors (toxicity) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Princess Margaret Cancer Centre status: RECRUITING city: Toronto state: Ontario zip: M5G 2J9 country: Canada name: Tara Rosewall role: CONTACT phone: 4162098269 email: tara.rosewall@rmp.uhn.ca name: Winnie Li role: CONTACT phone: 4169462000 email: winnie.li@uhn.ca lat: 43.70011 lon: -79.4163 hasResults: False
<|newrecord|> nctId: NCT06274879 id: 1938 Ablatio-bilica id: SNCPT type: OTHER domain: Portal for clinical trials in Switzerland briefTitle: Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer acronym: Ablatio overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2026-04-30 date: 2026-04-30 date: 2024-02-23 date: 2024-02-23 name: Insel Gruppe AG, University Hospital Bern class: OTHER name: Swiss Cancer League briefSummary: The goal of this clinical trial is to provide evidence for the general tolerability of radiofrequency ablation (bRFA) in patients with unresectable bile duct cancer undergoing systemic palliative treatment consisting of chemotherapy (gemcitabine and cisplatin) plus durvalumab (immune-checkpoint-inhibitor, ICI). The main question it aims to answer is whether it is safe to combine chemotherapy (gemcitabine and cisplatin) and immunotherapy (durvalumab) - CICI therapy.
Participants will be assigned to either the control group or the experimental group. In the control group, the standard of care consists of endoscopy with stent placement in the bile duct and CICI, whereas in the experimental group, bRFA will be performed in addition to the standard of care. Participants will be followed up for 6 months, during the follow-up, the stage of the tumor, blood examination, the duration of the stent from the insertion until its failure, adverse events and quality of life will be examined.
Researchers will compare the standard of care alone to the experimental group to see if the additional bRFA procedure causes higher or no difference in adverse events rate. conditions: Bile Duct Cancer studyType: INTERVENTIONAL phases: PHASE2 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 36 type: ESTIMATED name: Gemcitabin, Cisplatin and Durvalumab name: Biliary Radiofrequency Ablation name: Endoscopic Retrograde Cholangio-Pancreatography with stenting measure: Any grade 3 or 4 adverse events (AE) leading to chemo-immune checkpoint inhibitor-therapy (CICI) discontinuation up to six months after enrolment. measure: Endoscopic complications as measured by the Adverse events GastRointestEstinal Endoscopy (AGREE) criteria specifically developed for endoscopic interventions measure: Progression-free survival, which is defined as the time till the progression of disease or death, whatever comes first, from the time of enrolment to the end of follow-up. measure: Death from any cause from the time of enrolment to the end of follow-up (overall survival). measure: Development of disease-specific quality-of-life as measured by the EORTC QLQ-BIL21 before every CICI cycle plus at 3 and 6 months from the start of the CICI treatment measure: Change in health-related quality-of-life at baseline, 3 and 6 months from the start of the CICI treatment as measured by the EORTC QLQ-C30 measure: Stent patency at month 3 visit and end of study visit measure: Number of courses of CICI applied measure: Total dose of CICI applied measure: Details of adverse events measure: Prognostic significance of response to intraductal biliary RFA by genetic tumor characterization using next-generation sequencing measure: Overall survival sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Inselspital Bern University Hospital city: Bern state: Be zip: 3010 country: Switzerland name: Reiner Prof. Dr. med. Wiest role: CONTACT phone: +41 31 632 59 41 email: reiner.wiest@insel.ch name: Martin Prof. Dr. med. Berger role: CONTACT phone: +41 31 632 41 14 email: martin.berger@insel.ch name: Reiner Prof. Dr. med. Wiest role: PRINCIPAL_INVESTIGATOR name: Martin Prof. Dr. med. Berger role: SUB_INVESTIGATOR lat: 46.94809 lon: 7.44744 hasResults: False
<|newrecord|> nctId: NCT06274866 id: dsahinoglu briefTitle: Effects Of A Home Based Exercise Program Following Total Hip Arthroplasty overallStatus: ACTIVE_NOT_RECRUITING date: 2023-01-10 date: 2023-04-30 date: 2024-06-30 date: 2024-02-23 date: 2024-02-23 name: Halic University class: OTHER briefSummary: The aim of this study is to examine the effects of home-based exercise on pain-related factors, postural control and early functional parameters in individuals undergoing total hip arthroplasty. Forty-four individuals with hip osteoarthritis were included in current study. Individuals were randomized as study group (n=23) and control group (n=21) by drawing lots. Individuals in the study group were followed up with a personalized home-based exercise program for 6 weeks. Individuals in the control group were followed up with an exercise training brochure. The exercise program of the individuals in the study group was checked at two-week intervals and adjustments were made in the exercise program. All individuals were evaluated before the operation, 2 weeks after the operation, and 12 weeks after the operation, and their data were recorded. Range of motion was measured with an inclinometer, muscle strength was measured with a hand dynamometer, joint position sense was measured with a target angle test, pain was measured with a visual pain scale, leg length was measured with a tape measure, and finally, the Q angle was measured with a goniometer. In addition to these,Tampa kinesiophobia scale, Oxford hip score and international physical activity scale were used. Timed up-and-go test was used to evaluate functional performance. Foursquare step test was used to evaluate balance, and finally, tetrax posturography device was used to evaluate postural control. conditions: PHYSİOTHERAPY studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomize controlled two groups primaryPurpose: TREATMENT masking: NONE maskingDescription: no blinding count: 48 type: ACTUAL name: exercise program name: control group measure: OXFORD HİP SCORE measure: TAMPA SCALE FOR KINESİOPHOBİA measure: İNTERNATİONAL PHYSİCAL ACTİVİTY QUESTİONAİRE (SHORT FORM) measure: JOİNT POSİTİON SENSE ERROR TEST measure: FOUR SQUARE STEP TEST measure: THE TİMED UP and GO TEST measure: Assessment of Hip Muscle Strength measure: Assessment of Hip Joint Range of Motion measure: Assessment of Postural Control measure: MEASURİNG LEG LENGTH DİSCREPANCY measure: Q ANGLE sex: ALL minimumAge: 40 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Yeditepe Hospital city: Istanbul country: Turkey lat: 41.01384 lon: 28.94966 hasResults: False
<|newrecord|> nctId: NCT06274853 id: 170327-0001 id: 6830/0003 type: OTHER domain: ICON plc briefTitle: GS-441524 for COVID-19 SAD, FE, and MAD Study in Healthy Subjects overallStatus: NOT_YET_RECRUITING date: 2024-03-15 date: 2024-12 date: 2024-12 date: 2024-02-23 date: 2024-02-23 name: National Center for Advancing Translational Sciences (NCATS) class: NIH name: Leidos Biomedical Research, Inc. name: ICON Government and Public Health Solutions, Inc briefSummary: The goal of this clinical trial is to evaluate the safety, tolerability, and pharmacokinetics of GS-441524 in healthy subjects. The main questions to answer are: 1) What dosage of GS-441524 is required for adequate therapeutic plasma levels? 2) Does fed or fasted state produce variability in plasma levels? 3) How is GS-441524 eliminated from the body.
Participants will receive varying levels of GS-441524 or placebo to evaluate AEs and plasma levels. conditions: COVID-19 studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: SEQUENTIAL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 70 type: ESTIMATED name: GS-441524 name: Placebo measure: Treatment-emergent adverse events (TEAEs) measure: Blood Pressure in mm/Hg measure: Pulse in beats/min measure: Respiratory Rate in breaths per minute measure: Body Temperature in degrees measure: Electrocardiogram (ECG) as measured by PR interval measure: Electrocardiogram (ECG) as measured by QT interval measure: Electrocardiogram (ECG) as measured by QT corrected (Fridericia's) measure: Plasma PK Parameter C-Max measure: Plasma PK Parameter t-max measure: Plasma PK Parameter t-lag measure: Plasma PK Parameter AUC 0-last measure: Plasma PK Parameter AUC 0-inf measure: Plasma PK Parameter t 1/2 measure: Plasma PK Parameter CL/F measure: Plasma PK Parameter Vz/F measure: Urine PK Parameter Ae urine measure: Urine PK Parameter Fe urine measure: Urine PK Parameter CL R measure: Plasma PK Parameter C trough measure: Plasma PK Parameter AUC 0-tau measure: Plasma PK Parameter CL/F ss measure: Plasma PK Parameter Vz/F ss measure: Plasma PK Parameter R ac sex: ALL minimumAge: 18 Years maximumAge: 55 Years stdAges: ADULT hasResults: False
<|newrecord|> nctId: NCT06274840 id: CAR-CF briefTitle: COVID-19 Antibody Responses In Cystic Fibrosis acronym: CAR-CF overallStatus: RECRUITING date: 2022-08-08 date: 2024-05 date: 2024-05 date: 2024-02-23 date: 2024-02-23 name: Pilar Azevedo class: OTHER name: Queen's University, Belfast name: European Cystic Fibrosis Society - Clinical Trial Network name: Cystic Fibrosis Foundation name: Medical University Innsbruck briefSummary: Coronavirus disease 2019 (COVID-19) which is caused by the virus SARS-CoV-2 has resulted in an ongoing global pandemic. It is unclear whether the relatively low number of reported cases of COVID-19 in people with CF (pwCF) is due to enhanced infection prevention practices or whether pwCF have protective genetic/immune factors. This study aims to prospectively assess the proportion of pwCF, including both adults and children with CF who have evidence of SARS-CoV-2 antibodies over a two-year period. This study will also examine whether pwCF who have antibodies for SARS-CoV-2 have a different clinical presentation and what impact this has on their CF disease. The proposed study will recruit pwCF from paediatric and adult CF centres in Europe. Serological testing to detect antibodies will be performed on blood samples taken at month 0, 6, 12, 18 and 24 with additional time-points if bloodwork is available via normal clinical care. Clinical data on, lung function, CF-related medical history, pulmonary exacerbations, antibiotic use, and microbiology and vaccination receipt, will be collected during routine clinical assessments.
Associations will be examined between socio-demographic and clinical variables and serologic testing. The effects of SARS-CoV-2 infection on clinical outcomes and analyse end-points will be examined to explore any age-related or gender-based differences, as well as subgroup analysis of outcomes in lung-transplant recipients and pwCF receiving CFTR modulator therapies. As pwCF receive COVID-19 vaccination a comparison of the development and progression of anti-SARS-CoV-2 antibodies in pwCF following natural infection and vaccination SARS-CoV-2 over time will be performed. conditions: COVID-19 conditions: Cystic Fibrosis studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 1000 type: ESTIMATED measure: SARS-COV-2 seroprevalence measure: Association of SARS-CoV-2 seropositivity, clinical symptoms and clinical outcomes in pwCF measure: Longitudinal comparison of the detection measure: Serum proteomic and genomic responses of pwCF sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: CHLN status: RECRUITING city: Lisboa zip: 1800-268 country: Portugal name: Celeste Barreto role: CONTACT name: Ana Lopes role: CONTACT name: Celeste Barreto, MD role: PRINCIPAL_INVESTIGATOR lat: 38.71667 lon: -9.13333 hasResults: False
<|newrecord|> nctId: NCT06274827 id: GO 22- 881 briefTitle: Electromyographic Analysis of Scapular Muscles During Closed Kinetic Chain Exercises overallStatus: COMPLETED date: 2022-09-25 date: 2023-04-30 date: 2023-06-20 date: 2024-02-23 date: 2024-02-26 name: Hacettepe University class: OTHER briefSummary: In shoulder rehabilitation, the inclusion of kinetic chain exercises is advocated in order to provide the necessary energy transfer to produce optimal force with minimal energy consumption. Closed kinetic chain (CKC) exercises are defined as exercises in which the distal segment is stabilized by encountering significant resistance while the proximal segment moves. In contrast, open kinetic chain (OKC) exercises allow the distal segment to move freely without any resistance. Recently, the importance of closed kinetic chain (CKC) exercises has increased in enhancing shoulder joint neuromuscular control by improving dynamic shoulder stability and joint position sense.
The most current shoulder rehabilitation protocols include exercises for restoration of scapular muscle imbalances.There exist studies investigating the levels of scapular muscle activation during CKC exercises. Researchers have shown that most CKC exercises especially push-ups and plank variations with the shoulder in the 90° position, generally provide high SA activity and an optimal UT/SA ratio.In the literature, there is limited information on how the level of shoulder elevation affects scapular muscle activity and ratio during closed kinetic chain exercises in the prone position. To effectively prescribe CKC exercises commonly used in rehabilitation and athletic programs, a clear understanding of shoulder elevation changes muscle activity during these exercises is required.
Our hypothesis is that glenohumeral joint elevation status will alter scapular muscle activation and activation rates. conditions: Shoulder Pain conditions: Shoulder Injuries conditions: Activation, Patient studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: All participants will complete each stage in a randomized order. primaryPurpose: BASIC_SCIENCE masking: NONE count: 22 type: ACTUAL name: Superficial Electromyography measure: Muscle activation recorded with surface electromyography (sEMG) during CKC sex: MALE minimumAge: 18 Years maximumAge: 30 Years stdAges: ADULT facility: Hacettepe University city: Ankara zip: 06430 country: Turkey lat: 39.91987 lon: 32.85427 hasResults: False
<|newrecord|> nctId: NCT06274814 id: AP23.501.038 briefTitle: U/S Guided Rhomboid Intercostal Block Combined With Sub-Serratus Plane Block vs Type 2 Pectoral Nerve Block overallStatus: RECRUITING date: 2023-06-01 date: 2024-04-01 date: 2024-05-01 date: 2024-02-23 date: 2024-03-13 name: National Cancer Institute, Egypt class: OTHER briefSummary: The aim of this study is to compare between U/S Guided Rhomboid Intercostal Block Combined with Sub-Serratus Plane Block vs type 2 Pectoral Nerve Block in Analgesia for Breast Cancer Surgery by measuring intraoperative hemodynamics, postoperative pain scores and morphine consumption in the first 24 h postoperative. conditions: Breast Neoplasm Female conditions: Analgesics studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: SINGLE whoMasked: PARTICIPANT count: 69 type: ESTIMATED name: U/S guided Rhomboid intercostal block (RIB) name: U/S guided RIB combined with the sub-serratus plane block (RISS) measure: Total morphine consumption measure: Visual Analog scale score postoperative measure: Intraoperative fentanyl consumption measure: Heart rate intraoperative measure: Timing of first rescue analgesia sex: FEMALE minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: National cancer Insititute status: RECRUITING city: Cairo zip: 11796 country: Egypt name: attef, lecturer role: CONTACT phone: +20225328286 email: irb@nci.cu.edu.eg name: ahmed soliman role: PRINCIPAL_INVESTIGATOR lat: 30.06263 lon: 31.24967 hasResults: False
<|newrecord|> nctId: NCT06274801 id: GB002-3102 id: 2023-506334-75 type: EUDRACT_NUMBER briefTitle: Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) overallStatus: NOT_YET_RECRUITING date: 2024-06 date: 2026-12 date: 2026-12 date: 2024-02-23 date: 2024-02-23 name: GB002, Inc. class: INDUSTRY briefSummary: This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study conditions: Pulmonary Arterial Hypertension studyType: INTERVENTIONAL phases: PHASE3 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 300 type: ESTIMATED name: Seralutinib name: Gereic Dry Powder Inhaler measure: Incidence of treatment-emergent adverse events (TEAEs) measure: Changes in distance achieved on the Six-Minute Walk Test (6MWT) measure: Changes in NT-proBNP sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Kansas Medical Center city: Kansas City state: Kansas zip: 66160 country: United States lat: 39.11417 lon: -94.62746 facility: Pulmonary Associates of Richmond, Inc. city: Richmond state: Virginia zip: 23230 country: United States lat: 37.55376 lon: -77.46026 hasResults: False
<|newrecord|> nctId: NCT06274788 id: OMEG-054-CP4 briefTitle: Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2026-03-01 date: 2027-03-01 date: 2024-02-23 date: 2024-03-12 name: Fresenius Kabi class: INDUSTRY briefSummary: This study will demonstrate safety in pediatric patients with Parenteral Nutrition-Associated Cholestasis treated with Omegaven®, which is indicated as a source of calories and fatty acids in this patient population conditions: Parenteral Nutrition Associated Liver Disease (PNALD) conditions: Essential Fatty Acid Deficiency conditions: Malnutrition conditions: Pediatric ALL studyType: INTERVENTIONAL phases: PHASE4 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 40 type: ESTIMATED name: Omegaven® (fish oil triglycerides) Injectable Emulsion measure: Incidence of essential fatty acid deficiency (EFAD) measure: Incidence of clinical EFAD measure: Time from treatment start to EFAD diagnosis measure: Incidence of adverse events (AEs)/serious adverse events (SAEs) measure: Routine laboratory tests: Direct or conjugated bilirubin measure: Routine laboratory tests: triglycerides measure: Fatty acid profiles: α-linolenic acid measure: Fatty acid profiles: linoleic acid measure: Fatty acid profiles: arachidonic acid measure: Fatty acid profiles: mead acid measure: Fatty acid profiles: oleic acid measure: Fatty acid profiles: docosahexaenoic acid (DHA) measure: Fatty acid profiles: eicosapentaenoic acid (EPA) measure: Anthropometric measures: body weight measure: Anthropometric measures: body height/length measure: Anthropometric measures: head circumference sex: ALL minimumAge: 1 Day maximumAge: 17 Years stdAges: CHILD hasResults: False
<|newrecord|> nctId: NCT06274775 id: 23-12026811 briefTitle: Effect of an Educational Nail Biopsy Video on Pre-operative Anxiety, Health Literacy, and Patient Satisfaction overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2025-07 date: 2025-07 date: 2024-02-23 date: 2024-04-12 name: Weill Medical College of Cornell University class: OTHER briefSummary: The investigators are interested in studying the effect of an animated video depicting a nail biopsy procedure on the anxiety, health literacy, and satisfaction of participants recommended to undergo a nail biopsy procedure. The investigators hypothesize that the animated video will reduce preoperative anxiety, increase health literacy, and increase patient satisfaction in relation to nail biopsy procedures. conditions: Anxiety conditions: Literacy conditions: Satisfaction, Patient studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: SINGLE_GROUP primaryPurpose: OTHER masking: SINGLE whoMasked: PARTICIPANT count: 30 type: ESTIMATED name: Educational Video measure: Anxiety, as measured by the State Trait Anxiety Inventory measure: Anxiety, as measured by the Amsterdam Preoperative Anxiety and Information Scale measure: Need for information, as measured by the Amsterdam Preoperative Anxiety and Information Scale measure: Health literacy, as measured by 4 domains of The Health Literacy Questionnaire measure: Patient satisfaction, as measured by a patient satisfaction survey measure: Quality of video intervention for intervention participants, as measured by a qualitative feedback survey sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Weill Cornell Medicine city: New York state: New York zip: 10065 country: United States name: Shari R. Lipner, MD, PhD role: CONTACT email: shl9032@med.cornell.edu name: Rachel C Hill, BS role: CONTACT phone: 5024170984 email: shl9032@med.cornell.edu lat: 40.71427 lon: -74.00597 hasResults: False
<|newrecord|> nctId: NCT06274762 id: MARU-SBF-ROKÇ-01 briefTitle: Visually Impaired Women Model-based Cancer Education and Breast Self-examination overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-03-31 date: 2025-03-31 date: 2024-02-23 date: 2024-02-23 name: Marmara University class: OTHER briefSummary: The aim of our study was to raise awareness among visually impaired women, who are in the vulnerable group, about breast cancer, which ranks first among female cancers, and to teach breast self-examination. conditions: Breast Cancer Awareness and BSE in Visually Impaired Women studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: CROSSOVER interventionModelDescription: There is an experimental group of 45 visually impaired women aged 20-69 and a control group of 45. Randomization was not possible. Blinding could not be done. primaryPurpose: PREVENTION masking: NONE count: 90 type: ESTIMATED name: Training and BSE application on a model measure: Champion health belief model scale sex: FEMALE minimumAge: 20 Years maximumAge: 69 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Marmara University city: Istanbul country: Turkey name: Marmara University role: CONTACT email: sevalsaray.demir@gmail.com name: Seval Saraydemir Kıromeroglu role: PRINCIPAL_INVESTIGATOR lat: 41.01384 lon: 28.94966 hasResults: False
<|newrecord|> nctId: NCT06274749 id: 10001930 id: 001930-AG briefTitle: Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial overallStatus: RECRUITING date: 2024-05-01 date: 2027-03-31 date: 2027-03-31 date: 2024-02-23 date: 2024-04-26 name: National Institute on Aging (NIA) class: NIH briefSummary: Background:
As people age, the cells in the pancreas that produce insulin begin to release less of this hormone, and levels of blood glucose (sugar) rise. This can lead to illnesses such as diabetes. Urolithin A (UA) is a natural nutritional supplement that may improve how the body controls blood glucose.
Objective:
To learn if UA improves levels of insulin and other hormones that help control blood glucose.